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1. Introduction 
In this thesis I explore the connection between nonsense-mediated mRNA decay and type II 
survivor formation in the budding yeast Saccharomyces cerevisiae. The project described here 
was performed at the European Research Institute for the Biology of Ageing in Groningen in 
2016, in the framework of Dr. Michael Chang’s research focusing on telomeres and genome 
integrity. Relevant information about the key elements in my study has been found in published 
literature. 
1.1. Nonsense-mediated mRNA decay 
Cells have evolved several mRNA surveillance mechanisms that are used for the degradation of 
messenger RNA (mRNA) molecules with mutations. Consequently, the production of proteins 
with changed structure is prohibited so that no aberrant proteins can confer their toxic effect upon 
the cell. These mechanisms operate both in the nucleus and in the cytoplasm (Isken et al., 2007). 
One of the best studied surveillance mechanisms is the nonsense-mediated mRNA decay (NMD) 
pathway that selectively targets mRNA molecules bearing a premature termination codon (PTC). 
PTCs, also called premature stop codons, are caused by nonsense mutations which can arise 
already at the DNA level or as a consequence of mistakes made during transcription or RNA 
processing. Action of this pathway is confined to the cytoplasm and is closely linked to 
translation termination (Hug et al., 2016). According to Brogna and Wen (2009), NMD was 
discovered after it was observed that cells often contain a low amount of mRNAs which are 
transcribed from the alleles that carry nonsense mutations. It was shown that NMD is 
evolutionary conserved in eukaryotes, with more NMD factors required for functional response in 
more complex organisms. Surprisingly, the NMD pathway is also involved in the regulation of 
gene expression by monitoring the levels of mRNAs that do not contain PTCs. Such important 
and complex regulation would suggest the need for the presence of a buffering mechanism that 
would control the magnitude of the NMD response in accordance to specific genetic and/or 
environmental stimuli (Hug et al., 2016). Although many genes whose expression is controlled in 
such a way have been discovered, there is little overlap between the sets of such genes in 
different organisms and no correlation with any specific function (Brogna and Wen., 2009). 
While mRNAs are directly targeted and degraded by this pathway, expression of some genes is 
downregulated indirectly. Most likely, some of the target mRNA carry the information necessary 
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for the production of transcription factors or chromatin remodelers. In their absence, it is logical 
to assume that expression of their target genes would be affected (Guan et al., 2006). 
Another proposed function of the NMD pathway is in alternative splicing, where it could 
eliminate splice variants that contain PTCs or transcripts that have not been spliced. Nevertheless, 
studies have not been successful in finding the intimate link between NMD and alternative 
splicing (McGlincy et al., 2008). This pathway is not solely limited to mRNA, since long non-
coding RNAs are also used as substrates in S. cerevisiae, Arabidopsis and mouse embryonic stem 
cells (Hurt et al., 2013). 
 
1.2. NMD in Saccharomyces cerevisiae 
In S. cerevisiae three proteins comprise the NMD pathway, namely Upf1 (Nam7), Upf2 (Nmd2) 
and Upf3. The genes which code for the mentioned proteins are evolutionary conserved and 
represent a necessity for the operational NMD response (Conti et al., 2005). Upf1 is an ATP-
dependent RNA helicase of the SFI superfamily. Together with Upf2 and Upf3 it forms a trimeric 
complex that binds in the vicinity of a PTC. Eventually, the bound mRNA will be degraded and 
the emergence of truncated proteins will be prevented. One of the most important requirements 
for the NMD is to be specific towards PTCs only, while ignoring naturally occurring stop codons. 
According to Hug et al. (2016), “current models hypothesize that Upf1 is selectively recruited 
onto or activated on prematurely terminating ribosomes”. Aside from their function in unwinding 
secondary structures, RNA helicases can remain bound to a specific location on the RNA where 
they serve as “place markers”. It is believed that Upf1 clamps an mRNA at a specific position 
and recruits other proteins that are required for the formation of the degradation machinery 
(Cordin et al., 2006).  In the end, mRNA will be degraded by contributions from both the 5’–3’ 
decapping-dependent exonuclease pathway and the deadenylation dependent 3’–5’ exosome 
pathway. It was shown that Upf1 interacts with the decapping enzyme Dcp2 to promote Xrn1-
mediated decay from the 5’ end (Muhlrad and Parker, 1997) and with Ski7 to promote exosome-
mediated decay from the 3’ end (Mitchell and Tollervey, 2003). In their paper, Brogna and Wen 
(2009) describe two models that depict exactly how mRNAs with PTCs are distinguished. One 
model focuses on the importance of the downstream sequence elements (DSE) to which NMD 
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factors bind. Because there are several copies of DSEs across the coding part of an mRNA, the 
closer the PTC is to the beginning of the gene, the more probable that a DSE will be found 
downstream of it and that PTC will be recognized. As mentioned in the article, the main problem 
with this model is that there is no similarity between DSEs found on different mRNAs. The other 
model is called faux 3’-UTR model and it is applicable to yeast and Drosophila. It is based on the 
observation that mRNAs with prolonged 3’ untranslated regions (UTR) are NMD substrates, 
which emphasizes the importance of distance between PTC and 3’ UTR for the recognition of 
PTC and initiation of NMD response. Distinction between PTC and naturally occurring stop 
codons is made clear by the interaction between the poly(A) tail and the terminating ribosome 
(Figure 1). In the case of premature stoppage of the ribosome machinery interaction between the 
terminating ribosome and poly(A) binding protein (PABP) is prevented and association of NMD 
factors on the terminating ribosome is enabled. In the other case, translation termination takes 
place close to the 3’ UTR and it is dependent on the interaction between PABP and peptide-
release factor eRF3, which is associated with the terminating ribosome. Because PABP interacts 
with peptide-release factor eRF3, NMD factors cannot associate with the terminating ribosome 
and such mRNA is not “interpreted” as a substrate for NMD. As an argument for the accuracy of 
this model, authors explain that if PABP is artificially tethered close to the PTC, such PTC-
containing mRNAs will be stabilized.  
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Figure 1. Current NMD model in yeast and Drosophila, named faux 3’-UTR model (Brogna and Wen, 
2009). Normal termination depends on interaction between PABP, which is located on the poly (A) tail, 
and peptide-release factor eRF3 associated with the ribosome. In premature termination, interaction 
between PABP and the terminating ribosome is not possible due to the long distance between the 
ribosome and the poly(A) tail. Instead, the terminating ribosome interacts with NMD factors. 
 
1.3. Telomeres and survivor formation 
Telomeres are specialized nucleoprotein structures that are involved in protecting eukaryotic 
chromosome ends from fusing together or degradation, hence their importance for genome 
integrity. In budding yeast telomeres consist of ~350 base pairs (bp) of TG1-3/C1-3A repeats 
followed by a terminal single-stranded (ss) TG1-3 tract called G-overhang (Wellinger et al., 1993). 
As a consequence of aging, telomeres progressively shorten due to incomplete DNA replication. 
Progressive shortening of telomeres will in time result in the inability of the cell to divide. Such 
cells enter a state called replicative senescence, which can be avoided by the action of telomerase 
or by employment of the machinery required for homologous recombination. Telomerase is a 
reverse transcriptase that is crucial for the maintenance of telomeric ssDNA. This 
ribonucleoprotein adds telomeric repeats sequence to the 3’ G-overhang by using its intrinsic 
RNA template (Greider and Blackburn, 1985). Two subunits constitute the core of budding yeast 
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telomerase – the catalytic subunit Est2 and the RNA template subunit Tlc1. Two additional 
proteins required for telomerase activity in vivo are Est1 and Est3. Est1 interacts with the 
telomeric ssDNA-binding protein Cdc13 and recruits telomerase to telomere ends. In wild type 
cells, the telomerase pathway is the more predominant mechanism of telomere elongation as 
compared to the recombination pathway (Lingner et al., 1997). In telomerase-null cells, however, 
telomere elongation presumably depends solely on the recombination pathway. This telomerase-
independent recombination pathway is termed Alternative Lengthening of Telomeres (ALT). 
Most often, telomerase deficient yeast strains enter senescence after about 50-100 divisions, 
when telomeres reach their critical length of approximately 100 bp (Singer et al., 1994). 
Nevertheless, a few of these senescing cells can bypass the critical point by elongating their 
telomeres via the Rad52-dependent recombination pathway mentioned above. These cells are 
referred to as “survivors” and two survivor types, namely type I and type II, can be distinguished 
by their characteristic telomere patterns. In type I survivors, telomeres are extended by 
amplification of subtelomeric Y’ elements. Along with Rad52, formation of this type of survivors 
also depends on Rad51, Rad54, Rad55 and Rad57 (McEachern et al., 2006). Type II survivors 
exhibit sudden elongation of their telomeres by amplification of the TG1–3 telomeric repeats, 
which depends on the Mre11-Rad50-Xrs2 (MRX) complex and Rad59. Type I survivors are 
generated more frequently in solid-medium-grown cultures than type II: ~90% of newly formed 
survivors are type I and ~10% are type II. Although type I survivors are formed more often, type 
II survivors grow at faster rates, eventually exceeding their counterparts in sheer numbers when 
grown together in liquid culture (Hu et al., 2013).  
Recently, other genes involved in survivor formation have been identified. Hu and coworkers 
(2013) have identified 22 genes that are required for type II survivor generation. Among them 
there are 4 genes that are involved in NMD, namely UPF1, UPF2, UPF3 and EBS1. This 
observation suggests that NMD factors are directly involved in type II survivor formation or 
maintenance. Although this was reported several years ago, no models have yet been published 
and the exact molecular mechanism remains to be discovered.  
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1.4. Involvement of NMD in telomere biology 
As mentioned before, the NMD pathway also targets mRNAs which do not contain PTC and it is 
estimated that levels of around 600 RNAs are regulated in such a way. With regard to the latter, it 
is plausible to say that the action of the NMD pathway has severe physiological consequences. 
For example, yeast strains with impaired NMD have alterations in chromosome structure – the 
number of repeats in telomeres is reduced, the function of kinetochores is altered, gene silencing 
in silent regions of DNA near telomeres is impaired, etc. (Guan et al., 2006). The fact that yeast 
cells with impaired NMD show shorter telomere phenotype and faster telomere loss than wild 
type cells emphasizes the importance of NMD in telomere biology (Holstein et al., 2014). 
Enomoto and colleagues (2014) report that NMD accelerates the rate of senescence in telomerase 
deficient yeast strains. Their research has demonstrated that yeast cells with knock-out telomerase 
and with deletion of either UPF1 or UPF2 or UPF3 show a delayed senescence phenotype (e.g. 
est1Δ upf2Δ mutants senesce 23 to 28 PDs later than est1Δ). A plausible explanation would be 
that changes in mRNAs levels, caused by non-functional NMD, result in a decrease or an 
increase in the amount of certain proteins that effect the onset of senescence. When NMD 
response is disabled, the amount of several telomere related proteins as well as of RNAs is 
increased, for example the amount of telomerase subunits (Est1, Est2 and Est3), Ku complex, the 
Cdc13 partner proteins Stn1 and Ten1, and also Telomeric Repeat Containing RNA (TERRA) 
(Holstein et al., 2014).  
 
1.5. NMD regulates the expression of CST complex subunits 
In budding yeast proteins Cdc13, Stn1 and Ten1 form a trimeric complex (the so-called CST 
complex) that binds single stranded telomeric DNA. CDC13, STN1 and TEN1 are all essential 
genes and they are involved in the capping of telomeres. Since Stn1 and Ten1 bind ssDNA with 
lower affinity than Cdc13, it is considered that these proteins are recruited to telomeres via 
Cdc13. Except for its role in telomere end protection, CST is also known to interact with DNA 
polymerase alpha and this interaction is conserved (Holstein et al., 2014). The budding yeast CST 
complex still hasn’t been purified but other data suggest that CST functions as a 2:4:2 or 2:6:2 
complex (Lue et al., 2013). The three subunits of the complex show different functions, with 
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Cdc13 involved in recruitment of telomerase via interaction with Est1 and with Stn1 inhibiting 
telomerase activity by competing with Est1 for binding on Cdc13 (Holstein et al., 2014). It is also 
believed that Stn1 interacts with Pol12 and that, when overexpressed, it acts as an S phase 
checkpoint inhibitor. TEN1 is also required for chromosome end protection and regulation of 
telomere length (Enomoto et al., 2014). As mentioned before, NMD pathway regulates the 
expression of STN1 and TEN1, while expression of CDC13 is not affected by this pathway. 
Furthermore, if NMD pathway is disabled, the ratio of CST components at telomeres will change 
(Figure 2). To prove this, Holstein and coworkers (2014) used a chromatin immunoprecipitation 
(ChiP) assay to measure binding of myc-tagged Stn1, Ten1 and Cdc13 to telomeric DNA in 
nmd2Δ background. They reported that binding of Stn1, Ten1 and Cdc13 to telomeres in nmd2Δ 
mutants increased by 10-fold, 5-fold and 2-fold respectively. Interestingly, the same phenotype 
was observed when STN1 and TEN1 were overexpressed as in the case of NMD deletion 
(Dahlseid et al., 2013). The latter can be explained with the rise in the level of Stn1 when NMD 
is not functional. Consequently, Stn1 negatively regulates telomerase by competing for binding 
on Cdc13 with Est1. As a result, telomeres are maintained at shorter length. In telomerase 
deficient upfΔ strains, the levels of Stn1 protein are also increased, which could be the reason 
why senescence is delayed in such mutants. One possible explanation is that excess Stn1 
strengthens the telomere cap and chromosome ends are thus protected from degradation in 
telomerase-deficient cells (Addinall et al., 2011). Indeed, when Stn1 is overexpressed more of 
this protein is bound to telomeres independently of Cdc13 (Addinal et al., 2014). Since Stn1 has 
lower affinity for telomeric DNA than Cdc13, it is possible that Stn1 binds and caps the ends of 
telomeres by interacting with any of the other telomere binding proteins (e.g. Rap1, Rif1, Rif2, 
Ku, MRX, Tel1, telomerase, Sir proteins, RPA) or RNAs. The idea of Stn1 having 
physiologically important functions independently of Cdc13 is consistent with the data 
suggesting that the Ten1 interaction domain of Stn1 is much more critical for cell viability than 
the Cdc13 interaction domain (Petreaca et al., 2007).  
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Figure 2. NMD controls the ratio of CST components at telomeres. Levels of mRNAs transcribed from 
STN1 and TEN1 are directly controlled by NMD. If NMD pathway is not functional, concentration of 
bound CST subunits at telomeres will increase, especially in the case of Stn1 that can bind telomeric DNA 
without Cdc13. (Figure courtesy of Paula van Mourik)   
 
1.6. Aim of the study 
This study aims to investigate the link between nonsense-mediated mRNA decay and type II 
survivor formation in S. cerevisiae. As mentioned before, Hu and coworkers (2013) reported that 
NMD genes - UPF1, UPF2, UPF3 and EBS1 are required for type II survivor formation in 
BY4741 yeast strain background. The first stage of my study will establish whether UPF1, 
UPF2, UPF3 and EBS1 are required for type II survivor formation in W303 yeast strain 
background and compare the made observations to the ones reported in Hu et al. (2013). In the 
second stage, I will focus on the exact link between NMD and survivor formation. As described 
in more detail in section 1.5, several observations that link NMD, CST complex and senescence 
have been reported. The fact that the overproduction of Stn1 results in the same senescing 
phenotype as has been observed for mutants with non-functional NMD, and the fact that binding 
of Stn1 to telomeres is increased in such mutants, suggest an additional function of Stn1, along 
with the ones it performs together with other subunits of the CST complex. It is possible that the 
presence of additional Stn1 at telomeres could intervene with recombination events that lead to 
survivor formation, explaining why a functional NMD pathway is required for type II survivor 
formation. These insights have prompted the idea to check whether Stn1 is the reason why NMD 
mutants are unable to form type II survivors.    
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2. Materials and methods 
2.1. Yeast strains and media 
All of the strains used in this study were RAD5 derivatives of W303 (Thomas and Rothstein, 
1989). In order to determine which NMD genes were required for type II survivor formation, 
NMD genes were individually deleted in the strain YPM9. This strain was previously created in 
Dr. Chang’s laboratory and it harbored the gene deletions of EST2 and RAD51. EST2 codes for 
the catalytic subunit of telomerase and RAD51 promotes strand invasion in homologous 
recombination and is necessary for type I survivor formation. Yeast cells in which EST2 and 
RAD51 are deleted cannot maintain and prolong their telomeres via telomerase or by 
recombination events leading to type I survivor formation. By deleting a certain gene in YPM9 
strain and evaluating whether such cells can form type II survivors, it is possible to screen for 
genes important for type II survivor formation.  
Next, to assess the potential function of STN1 in blocking the formation of type II survivors, 
STN1 was overexpressed in YPM9 strain. Along with YPM9, CCY6 and CCY7 strains were also 
used in the study. In these strains, RAD51 was overexpressed in order to see whether this would 
affect type II survivor formation. CCY6 harbors a deletion of EST2, while CCY7 strain is 
characterized by the deletion of TLC1 that encodes the RNA template component of telomerase.  
Listed in Table 1 are all the strains that were used in this study. 
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Table 1. Strains constructed in order to verify the existence and establish the nature of the link 
between NMD and type II survivor formation. 
Strain Genotype Source 
YPM9 MATa/α est2::URA3/EST2 rad51::natMX4/RAD51  
Laboratory 
collection 
CCY6 MATa/α est2::URA3/EST2 
Laboratory 
collection 
CCY7 MATa/α tlc1::HIS3/TLC1 
Laboratory 
collection 
AKY1 MATa/α est2::URA3/EST2 rad51::natMX4/RAD51  upf1::kanMX4/UPF1 This study 
AKY2 MATa/α est2::URA3/EST2 rad51::natMX4/RAD51 upf3::kanMX4/UPF3 This study 
AKY3 MATa/α est2::URA3/EST2 rad51::natMX4/RAD51 CUpr-STN1/STN1 This study 
AKY4 MATa/α est2::URA3/EST2 rad51::natMX4/RAD51 GALpr-STN1/STN1 This study 
AKY5 MATa/α est2::URA3/EST2 GALpr-RAD51/RAD51 This study 
AKY6 MATa/α tlc1::HIS3/TLC1 GALpr-RAD51/RAD51 This study 
AKY7 MATa/α est2::URA3/EST2 rad51::natMX4/RAD51 upf2::kanMX4/UPF2 This study 
AKY8 MATa/α est2::URA3/EST2 rad51::natMX4/RAD51 ebs1::kanMX4/EBS1 This study 
 
Three growth media were used while working with the described strains – yeast extract-peptone-
dextrose (YPD), yeast extract-peptone-dextrose with added CuSO4 (YPD+Cu) and yeast extract-
peptone-galactose (YPGal). YPD and YPGal were used for single-colony streaking assays and 
liquid senescence assays. YPD+Cu was used only for the single-colony streaking assay. The 
media were prepared according to the recipe in Appendix I. 
 
2.2. LiAC transformation 
YPM9, CCY6 and CCY7 strains were transformed by lithium acetate (LiAc) method, where 
LiAc was used to permeabilize the cell wall of yeast cells. Overnight (O/N) cultures were grown 
in 5 ml YPD medium in rotating wheel in the incubator at 30oC. The following day, cell density 
of the O/N culture was measured with a spectrophotometer. Based on the measured OD600, a new 
culture was grown to mid log-phase (OD600=0.4 to 0.8). These cells were then pelleted, washed 
with dH2O, pelleted again and then resuspended in 1xTE/LiAc buffer. 50µL of the prepared yeast 
suspension was transferred to a new 1.5 ml Eppendorf tube together with 10-15 µL DNA (PCR 
product) and 5-10 µL ssDNA (50-100 µg was used for 1 transformation). 400 µL of 40% 
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PEG400 solution was added to the previously prepared transformation mixture. The tubes were 
incubated for 30 minutes at 30oC and heat shocked in a water bath at 42oC for 40-45 minutes. 
The cells were spinned down, resuspended in 200 µl YPD medium and let to grow for 1-2 hours 
in the incubator at 30oC. 200 µL of the cell culture was plated on YPD plates, which were then 
incubated for 1 day at 30oC. Finally, the colonies were replica plated on appropriate selection 
plates to select for the strains in which construct was integrated in the genome. The plates were 
incubated for 1-2 days at 30oC 
Solutions used for strain transformation are listed in Appendix II. 
 
2.3. Polymerase-chain reaction (PCR) 
UPF1, UPF2, UPF3 and EBS1 deletion mutants were identified in Yeast Knock-Out MATa 
collection. This collection contains mutants in which a certain gene is deleted and replaced with 
the insertion of the kanamycin-resistance marker (kanMX) cassette. Genomic DNA (gDNA) was 
isolated from the mentioned mutants according to the protocol in Wizard® Genomic DNA 
Purification Kit (Promega). PCR was used to obtain the gene deletions containing a kanamycin-
resistance marker that confers resistance to the antibiotic geneticin. PCR was set up according to 
the protocol from the Phusion High-Fidelity DNA Polymerase (Biolabs) manual. For every gene 
of interest, a pair of primers that bind 300-500 bp upstream and downstream of the gene was 
constructed (Table 2).  
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Table 2. Primers used for PCR reactions 
Primer Primer sequence Description 
UPF1_f 5’-TTAATGAATTCATGAACGGGA-3’ Primers bind 420 bp and 
300 bp upstream and 
downstream of the UPF1 
respectively 
UPF1_r 5’-CTTTATTACGCATTGCAGTGC-3’ 
NMD2_f 5’-TGATACGAATTGATGGAGCCTG-3’ Primers bind 300-400 bp 
upstream and downstream 
of UPF2 NMD2_r 5’-TACAGCGGTGGTAAAGAAGAC-3’ 
UPF3_f 5’-GGATTTTATTGCCGTCTTTTT-3’ Primers bind 420 bp 
upstream and downstream 
of UPF3 UPF3_r 5’-TTTATTTAGTCGGGGTTGTGG-3’ 
EBS1_f 5’-CGGGAAATATCACAATGGAAG-3’ Primers bind 430 bp 
upstream and downstream 
of EBS1 EBS1_r 5’-TGACGCGTTCAAACCAGATT-3’ 
kanB_r 5’-CTGCAGCGAGGAGCCGTAAT-3’ Binds onto kanMX cassette 
STN1_S1 
5’-GGGACAGAGGACGTTCGAATATTTGTTGGAGA 
TTTAAAGTACCGGATGCGTACGCTGCAGGTCGAC-
3’ 
3’-end sequence of the 
primers enables binding 
to the pymN-1 and 
pymN-22, while 5’-end 
sequence is homologues 
to the region upstream 
and downstream  
of STN1 
STN1_S4 5’-ATAACAAACATCGCCTTCTTGATGAGCTATAT GTCCGTACTTATCCATCGATGAATTCTCTGTCG-3’ 
RAD51_S1 5’-CGTAGTTATTTGTTAAAGGCCTACTAATTTG TTATCGTCATATGCGTACGCTGCAGGTCGAC-3’ 
3’-end sequence of the 
primers enables binding 
to the pymN-1 and 
pymN-22, while 5’-end 
sequence is homologues 
to the region upstream 
and downstream of 
RAD51 
RAD51_S4 5’-CCGTACTGAAGCTGTGACTCTGATATATGTTT TCTTGAACTTGAGACATCGATGAATTCTCTGTCG-3’ 
STN1_f 5’-ATGGGCAAAGTCACTCAGAA-3’ Primers bind 200bp 
upstream and downstream 
of STN1 STN1_r 5’-AAAGCGACGGTTTTTGTCTT-3’ 
RAD51_f 5’-TGGACGGTAAATGTTGGA-3’ Primers bind 200bp 
upstream and downstream 
of RAD51 RAD51_r 5’-CGTCGAAACGAAGACAAG-3’ 
 
Sequences of UPF1, UPF2, UPF3 and EBS1 were taken from the Saccharomyces Genome 
Database (SGD). 
In all of the PCR reactions in this study, Phusion® High-Fidelity DNA Polymerase (BioLab inc.) 
for amplification of DNA and 5X Phusion HF Buffer were used. The substances used and their 
final concentration are listed in Table 3 below. Table 4 contains parameter values for each step in 
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the PCR reaction. Gel electrophoresis was carried out in a horizontal tank containing 1xTE buffer 
and was run at 120 V for 30 minutes.  
After the transformation of YPM9 strain, integration of the gene deletions was checked with 
PCR. Reaction mixture was set up according to the Table 3, the only difference being in the 
reverse primer used (in this case kanMX primer KanB). Except for the annealing temperature (Ta) 
and extension time, PCR conditions were the same as the ones specified in Table 4. Ta was set to 
56oC in the case of UPF1, EBS1, UPF2 and to 55oC in the case of UPF3 gene deletions. 
Extension time was 30 seconds (for UPF1), 45 seconds (for EBS1) and 60 seconds (for UPF2 
and UPF3).  
Table 3. PCR reaction mixture used to amplify UPF1, UPF2, UPF3 and EBS1 deletions  
  Component 50 µl reaction Final concentration 
  5x HF buffer 10   µl 1x 
  Primer FW 2.5 µl 10 µM 
  Primer RV 2.5 µl 10 µM 
  dNTPs 1  µl 10 mM 
 Phusion DNA 
polymerase 0.5 µl 
1.0 unit/50 μl 
PCR 
gDNA 1   µl 50-250 ng/µL 
Nuclease- Free 
Water 32.5 µl 
 
 
Table 4. PCR conditions for amplification of the UPF1, UPF2, UPF3 and EBS1 deletions 
Step Temp oC Time Cycles 
Initial 
denaturation 98 30 sec 1 
    Denaturation 98 10 sec 30-40 
Annealing 56 30 sec 30-40 
Extension 72 * 30-40 
    Final extension 72 5 min 1 
    Hold 4 ∞ 
 * extension time was 70 seconds in the case of UPF1, UPF2, UPF3 
   and 45 seconds in the case of EBS1 
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2.4. Strain construction for STN1 overexpression  
In order to overexpress STN1 in YPM9 strain the strategy described in Janke et al. (2004) was 
followed. The strategy requires: (a) a pair of primers that contain sequences of homology to the 
genomic target location within their 5’ region; and (b) PCR-cassettes (also termed ‘modules’) 
that can be ampliﬁed using these primers. PCR-cassettes are located on different plasmids and 
contain a specific combination of promoters, selection markers and tags. There are many different 
modules so one can choose between them and select the one that carries the desired promotor, 
marker and/or tag. The strategy for overexpression of STN1 is based on integration of a specific 
promotor in front of the gene. Two promotors were used in this study, galactose promotor 
(GALpr) and copper promotor (CUpr). Janke and associates (2004) named plasmids that carry 
these promotors pymN-1 (contains CUpr) and pymN-22 (contains GALpr). Except for 
promotors, the PCR modules of pymN-1 and pymN-22 also carry kanMX4 cassette. According to 
the strategy described in the article, primers S1 and S4 should be used with pymN-1 and       
pymN-22 to successfully amplify CUpr/GALpr and kanMX4 cassette (Figure 3). Bearing in mind 
that in the end CUpr/GALpr and kanMX4 cassette should be integrated in front of STN1, primers 
that were identical to S1 and S4 primers were constructed, except for the additional 5’ nucleotide 
sequence that was homologous to the genomic nucleotide sequence upstream of the STN1  
(Figure 4). The sequence of each primer is shown in Table 2. Because these primers are identical 
in sequence to S1 and S4 primers, they bind to pymN-1 and pymN-22 module and amplify the 
desired promoter and marker.  
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Figure 3. Amplification of PCR cassette. Each plasmid contains a PCR cassette, which consists of 
selection marker, promoter sequences and/or sequences that encode for a tag. From a diverse collection of 
such plasmids described in Janke et al. (2004), pymN-1 and pymN-22 was used. Their PCR cassettes both 
contain kanamycin resistance marker, along with CUpr (pymN-1) or GALpr (pymN-22), while none of 
them contains any sequence that encodes for a tag. S1- and S4-primers allow amplification of cassettes of 
pymN-1 and pymN-22.  (Adapted from Janke et al., 2004) 
 
 
Figure 4. Primer design (Janke et al., 2004). The 5’ end of S1-primer consists of 45–55 bases that are 
homologous to the sequence upstream of the ATG (including ATG = start codon) of STN1. The 3’ end 
contains the 5-CGTACGCTGCAGGTCGAC-3 sequence, which enables binding of the primer to 
appropriate PCR modules. The 5’ end of S4-primer is the reverse complement of 45–55 bases downstream 
of the ATG (start-codon) of STN1 (excluding ATG) and the 3’ end consists of the                                      
5-CATCGATGAATTCTCTGTCG-3 sequence, crucial for binding to appropriate PCR modules. 
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PCR cassettes of pymN-1 and pymN-22 were amplified according to the protocol for hot-start 
PCR that is used in Dr. Chang’s laboratory. The components used and their final concentrations 
are shown in Tables 5 and 6 below. Steps of the PCR program are listed and described in Table 7. 
After PCR, amplicons were transformed in YPM9 strain. The constructs were integrated in front 
of STN1, enabling overexpression of STN1 by addition of galactose or copper to the media. 
The same procedure was performed in the case of CCY6 and CCY7 strains, in which RAD51 
using GALpr was overexpressed. Used primers are presented in Table 2. 
Integration of the promoter at the specific location in the genome was later checked by PCR. 
Reaction mixture was set up according to Table 3, the only difference being the primers used. For 
proving the integration of PCR cassette in front of STN1, primers STN1_f and STN1_r were 
constructed (Table 2). In the case of RAD51, primers RAD51_f and RAD51_r were used     
(Table 2). Except for the annealing temperature (Ta) and extension time, PCR conditions were the 
same as the ones specified in Table 4. For proving the integration of PCR cassette in front of 
STN1 and RAD51, Ta and extension time were set to 55oC and 60 seconds respectively.  
 
Table 5 PCR mix 1 for amplification of pymN-1 and pymN-22 PCR cassettes  
                                  Mix 1  
Component 40 µl reaction 
Final 
concentration 
5x HF buffer 8 µl 1x 
Primer FW 1 µl 10 µM 
Primer RV 1 µl 10 µM 
dNTPs 1 µl 10 mM 
DNA (plasmid) 1 µl 10-20 ng/40µl 
Nuclease-Free 
Water 28 µl 
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Table 6 PCR mix 2 for amplification of pymN-1 and pymN-22 PCR cassettes 
 
 
 
 
 
 
 
 
Table 7 Hot-start PCR program 
PCR mix Step Temp oC Time Cycles 
Mix1 
Initial 
denaturation 95 5 min ∞ 
     Add mix 2 Denaturation 95 30 sec 30 
 
Annealing 68 30 sec 30 
 
Extension 72 30 sec 30 
     
 
Final extension 72 10 min 1 
     
 
Hold 4 ∞ 
  
 
 
 
 
                         Mix 2  
Substances 10 µl reaction 
Final 
concentration 
5x HF buffer 2 µl 1x 
Phusion DNA 
polymerase 0.25 µl 0.5 units/10  µl 
Nuclease-Free  
Water 7.75 µl  
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2.5. Tetrad dissection and mutant selection 
After evaluating the success of the transformations described in 2.1., the same procedure was 
followed each time: the transformants were streaked on minSPO plates (see Appendix I) and 
incubated at 22oC for 7-10 days. Over that period of time, yeast cells underwent sporulation. 
Cells were taken from each plate and were put into an Eppendorf tube that already contained 
zymolyase solution (concentration 0.5 mg/ml). The tubes were incubated for 15 minutes at room 
temperature (RT). After the lysis of yeast cell walls by zymolyase, solution from one tube was 
spread on YPD plate and further analyzed with dissection microscope. Separation of ascospores 
from individual asci was carried out with a glass microneedle attached to the micromanipulator 
on the dissection microscope. Ascospores were organized in 12 rows on a single YPD plate, each 
row containing four ascospores from one ascus. In the case of AKY3 and AKY4 strain, tetrad 
dissection was performed both on YPD and YPD+Cu or YPGal plates respectively. After 3-4 day 
incubation at 30oC, newly formed colonies were replica plated on selection plates. The tetrads 
plates from strains AKY1-4, AKY7 and AKY8 were replica plated on YPD+G418, YPD+NAT 
and SD-URA plates (for ingredients see Appendix I). In the case of AKY5 and AKY6 strains, 
colonies on each YPD plate were replica plated on YPD+G418, SD-URA and SD-HIS plates.  
After 24-hour incubation, 2:2 segregation of the markers linked to the gene deletion was 
observed. In the case of AKY1-4, AKY7 and AKY8 strains, single (est2∆URA3), double 
(est2∆URA3 rad51∆natMX4, est2∆URA3 xxx∆kanMX4 and rad51∆natMX4xxx∆kanMX4) and 
triple (est2∆URA3 rad51∆natMX4 xxx∆kanMX4) mutants were identified. With AKY5 and 
AKY6 strains single (est2∆URA3, tlc1∆HIS3, GALpr-RAD51) and double (est2∆URA3 GALpr-
rad51, tlc1∆HIS3 GALpr-RAD51) mutants were observed. 
 
2.6. Single-colony streaking assay 
After tetrad dissection and identification of the mutants listed in the previous paragraph, a single-
colony streaking assay was performed to determine whether mutants are able to form type II 
survivors. Single, double and triple mutants were streaked on separate YPD plates, divided into 6 
sections. The mutants were initially streaked only on the first section of each plate, after which 
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the plates were incubated for 3 days at 30oC. During the incubation new colonies formed and one 
of them was taken from the first section and streaked on the second section of the same plate. 
Plates were then again incubated for 3 days at 30oC.  The described streaking procedure was 
repeated 5 times in total. During the procedure, mutants started senescing and afterwards formed 
type II survivors or died. 
To test the effect of overexpressing STN1 or RAD51, strains AKY3, AKY4, AKY5 and AKY6 
were streaked on both YPD and YPD+Cu or YPGal plates as described above.  
 
2.7. Liquid senescence assay 
After tetrad dissection and identification of mutants, colonies of single, double and triple mutants 
were inoculated O/N in 2.5 ml of the appropriate liquid medium at 30oC.  The next day, which 
represented day 0 time point, the cell density of the O/N culture was measured using CASY cell 
counter (Roche Life Science). Since cell density of the O/N cultures was too high to measure 
directly, dilutions described below were prepared. 100 µl of the O/N culture was diluted in 900µl 
dH2O in a 1.5 ml Eppendorf tube. 10µl of the solution was then added to 10 ml of CASY buffer. 
Cell density was measured in order to calculate the exact volumes of O/N cultures that had to be 
added to 5 ml of YPD or YPGal medium for the final concentration of cells in every new tube to 
be 2x105 cells/ml. Cultures were then grown for 24 hours at 30oC. The following day, which 
represented day 1 time point, the procedure described above was repeated - cell density was 
measured and new cultures with identical starting concentration of yeast cells were prepared. 
These cultures were once again grown for 24 hours. The same procedure was repeated for the 
next ten days. Every day, cells were taken for Southern blot analysis.  
In this assay, cell density of every culture was measured over 10 days. Telomerase-deficient yeast 
cells were dividing in the liquid culture until they reached senescence, after which the rate of 
culture growth started decreasing. However, upon further incubation, cell density started 
increasing again because the telomeres were elongated by recombination-based telomere 
maintenance mechanism (Figure 5). The main objective of this assay was to determine the growth 
phenotype of the mutants and determine whether single, double and triple mutants would be able 
to form survivor cells. 
20 
 
 
Figure 5. Events influencing growth rate changes during liquid senescence assay. In telomerase-deficient 
yeast cells, telomeres shorten progressively. When the telomeres reach their critical length, cells enter a 
state that blocks cell division, termed senescence. As a result, growth rate will progressively decrease 
since the number of cells that have entered senescence is increasing. Some cells will bypass the 
senescence by prolonging their telomeres through recombination-mediated events, giving rise to survivors. 
 
2.8. Telomere Southern blot 
Genomic DNA was isolated from samples collected during liquid senescence assay using 
Wizard® Genomic DNA Purification Kit (Promega). Isolated gDNA was digested overnight with 
XhoI at 37oC and separated on 1% agarose gel with EtBr that was run for 10 minutes at 100 V 
and then for 2-3 hours at 120 V. DNA was depurinated by incubation of the gel in 0.25 M HCL 
for 15 minutes followed by denaturation of the gel for 30 minutes in 0.4 M NaOH. DNA was 
transferred to a Hybond-N+ membrane (GE Healthcare) by vacuum transfer method (5 Hg for 60 
minutes in 10xSSC buffer). Afterwards, the membrane was rocked for 1 hour in denaturation 
solution and later on for 2x10 minutes in neutralization solution at RT. The membrane was then 
pre-hybridized in hybridization incubator in 20 ml pre-warmed DIG easy hyb buffer (Roche) at 
39oC for 1 hour. The membrane was probed with TG1-3 telomere-specific probe labeled with 
digoxigenin (DIG, probe was labelled according to the DIG oligonucleotide 3’-end labelling kit, 
2nd generation Roche). Hybridization happened overnight at 39oC. Next day, the membrane was 
washed 2x5 minutes with pre-warmed 2xSSC + 0.1% SDS and then 2x20 minutes with pre-
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warmed 0.5xSSC + 0.1% SDS at 39oC.  After the washing steps, the membrane was briefly 
rinsed in 25 ml of 1x DIG wash buffer and then blocked for 30 minutes with 10 ml of 1x 
blocking solution at RT. The probe was marked with AP-coupled anti-DIG Fab (Roche) that was 
diluted in 10 ml 1x blocking solution (1:10000 dilution) and membrane incubation lasted for 30 
minutes at RT. In the end, 1 ml of solution of DIG detection buffer with CSPD (100x diluted) 
was spread over the membrane, which was incubated for 5 minutes in the dark and then for 15 
minutes at 37oC, the latter ensuring that the signal would be enhanced. Samples were visualized 
by using the Chemidoc system.  
Solutions that were prepared for Southern blot are listed in Appendix III. After preparation, the 
solutions were autoclaved and stored at RT. 
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3. Results 
3.1. Assessing the outcome of AKY1-AKY8 strain creation 
As mentioned in section 2.1., strains AKY1-AKY8 were created by transforming YPM9, CCY6 
and CCY7 strains with the appropriate construct. This section describes the results which confirm 
the success of the transformation and prove the accuracy of construct integration at the specific 
position in the genome.  
After genomic DNA (gDNA) of UPF1, UPF2, UPF3 and EBS1 deletion mutants was isolated 
and the respective gene deletions containing a kanMX marker were amplified, the PCR products 
were transformed into YPM9. The specificity of the integration of the products was checked with 
PCR (Figure 6). Forward primers that bind ~400 bp upstream of the deleted genes and a reverse 
primer that binds to the kanMX cassette were used. In order for the transformation to be deemed 
successful and specific, the primers had to amplify the region of around 1800 bp in each reaction. 
Amplicons thus had to contain almost whole kanMX cassette sequence which is 1506 bp long and 
a ~400 bp long sequence upstream of the target gene deletion. PCR products were analysed on 
1% agarose gel and stained with ethidium bromide (EtBr). With all the transformants, the 
obtained PCR products were around 1800 bp long, which proved the efficient construction of 
AKY1, AKY2, AKY7 and AKY8 strains. 
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Figure 6. PCRs performed to evaluate AKY1/AKY2 (A), AKY7 (B) and AKY8 (C) strain construction. 
PCR products (~1800 bp long) representing UPF1/UPF3, UPF2 and EBS1 deletions are seen on the gels. 
Strong band representing the ~700 bp fragment (C) is caused by unspecific amplification. 
The strategy for the overexpression of STN1 and RAD51 included integration of pymN-1 and 
pymN-22 PCR cassettes upstream of STN1 or RAD51. The length of the pymN-1 and pymN-22 
PCR cassettes was 1990 bp and 1978 bp respectively. As described in section 2.3., a specific pair 
of primers whose 3’ ends enabled binding to the appropriate PCR modules and whose 5’ ends 
were homologous to the region upstream and downstream of STN1 or RAD51 was constructed. 
Firstly, these primers were used for amplification of PCR cassettes of pymN-1 and pymN-22. 
Secondly, the obtained amplicons were transformed into YPM9 or CCY6 and CCY7 strain. 
Accuracy of the integration of the cassettes was checked with PCR. Primers were constructed so 
that the forward primer bound ~200 bp upstream of the start codon while the reverse primer 
bound ~200 bp downstream of the stop codon of either STN1 or RAD51. Hence, if the integration 
of PCR cassettes was specific, primers had to amplify the region that contained both the 
integrated PCR cassette and either STN1 or RAD51. The length of PCR cassettes from pymN-1 
and pymN-22 was 1990 bp and 1978 bp respectively. Since STN1 is 1485 bp long, the PCR 
products in total had to be 3828 bp (for pymN-1 cassette) and 3816 bp (for pymN-22 cassette); in 
the case of 1203 bp long RAD51, the PCR product had to be 3581 bp (for pymN-22 cassette).  
Nevertheless, since the analyzed transformants were diploids, a PCR cassette was integrated only 
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in front of one copy of the gene of interest. Because of that, it was also expected that the primers 
would amplify only STN1 or RAD51 so that additional bands ~400 bp longer than the two genes 
would be seen on the gel. The PCR products were analyzed on 1% agarose gel and stained with 
EtBr. Pictures of gels are shown in Figure 7. The PCR products that suggest precise integration of 
PCR cassettes are marked in green. The bands with the strongest signal represent STN1 and 
RAD51 upstream of which integration of PCR cassettes did not occur. Other bands are a 
consequence of non-specific binding of the primers.  
 
 
                                                                         
Figure 7. (A) PCR performed to prove the integration of PCR cassettes from pymN-1 and pymN-22 in 
front of STN1. A fragment of the expected size, 3828 bp for pymN-1 cassette and 3816 bp for pymN-22 
cassette, is seen on the gel for each of the two strains (AKY3 and AKY4). The bands representing these 
fragments are marked in green. (B) PCR performed to prove the integration of PCR cassette from pymN-
22 in front of RAD51. The band representing the fragment of the expected size (~3581 bp) is marked in 
green.   
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3.2. Importance of UPF1 and UPF3 for type II survivor formation 
In order to investigate whether type II survivor formation depends on UPF1 and UPF3, I created 
knock-out mutants of the mentioned genes and observed if they would be able to form type II 
survivors. After the sporulation of AKY1 and AKY2, tetrad dissection was performed. Based on 
the ability of cells to form colonies on YPD+G418, YPD+NAT and SD-URA plates, single, 
double and triple mutants were identified. The mutants were then streaked on YPD plates and 
single-colony streaking assay was performed. For each strain I streaked 10 single, 20 double and 
20 triple mutants. All of them were telomerase-deficient, which meant that yeast cells were able 
to divide only a certain number of times before they started senescing. As expected, a small 
number of cells formed survivors and thus bypassed senescence. When the number of colonies 
started rising, the new colonies were most likely formed from survivor cells. In the case of 
telomerase-deficient mutants with RAD51 deleted, it is believed that such colonies were formed 
from type II survivors. In other instances cells senesced and no new colonies formed in later 
sections of the plate. Such an outcome in case of triple mutants indicated that the deleted gene 
was somehow involved in type II survivor formation. At the end of the streaking assay, I counted 
the plates on which survivors formed. The other plates contained mutants that senesced and were 
not able to form survivors. Such mutants were named dropouts (DOs). Percentage of DOs was 
calculated for single, double and triple mutants.  
Results of single-colony streaking assay are shown in table 8 (for AKY 1 strain) and table 9 (for 
AKY2 strain). It can be seen from the tables that all of the single mutants (est2Δ) overcame 
senesce and that percentage of DOs therefore equaled 0. This was expected since single mutants 
were able to form both types of survivors.  
Based on literature, double mutant est2Δ rad51Δ was expected to be unable to form type I 
survivors whose generation is dependent on RAD51. With regard to est2Δ upf1Δ or est2Δ upf3Δ 
mutants, if UPF1 and UPF3 were indeed required for type II survivor formation, only type I 
survivors were expected to form. Since all of the mentioned double mutants were able to form a 
certain type of survivors, no DOs were expected. Surprisingly, the percentage of DOs for est2Δ 
rad51Δ mutant from both AKY1 and AKY2 strain was noticeably high – 60% and 40% 
respectively. A plausible explanation of such an outcome had to do with the generally low 
26 
 
incidence of type II survivor formation and the possibility that survivor colonies were not picked 
and restreaked during single-colony streaking assay. This would be in line with the fact that a 
frequent occurrence of est2Δ rad51Δ DOs was also observed in other single-colony streaking 
assays performed earlier in the laboratory. As expected, no DOs of est2Δ upf1Δ or est2Δ upf3Δ 
mutants were observed. 
Occurrence of DOs was most frequent in the case of triple mutants. This could indicate that both 
UPF1 and UPF3 are somehow required for type II survivor formation since deletion of these 
genes results in an increased number of DOs. Although the percentage of triple mutant DOs was 
high, the observed number of est2Δ rad51Δ DOs made it difficult to assess to what degree the 
deletion of UPF1 or UPF3 influenced type II survivor formation. This was particularly the case 
with AKY1 strain, where, in comparison to est2Δ rad51Δ mutants, deletion of UPF1 only raised 
the percentage of DOs by additional 20%. Based solely on this result, it was difficult to claim that 
this increase in number of DOs was significant and sufficiently high to mean that UPF1 deletion 
disturbed type II survivor formation. For AKY2 strain, the percentage of triple mutant DOs was 2 
times higher than in the case of est2Δ rad51Δ mutant. In my opinion, this result could indicate 
that UPF3 is required for type II survivor formation. 
Table 8. Single-colony streaking assay performed with mutants of the indicated genotypes, derived from 
the sporulation of AKY1. The mutants were examined for the ability to bypass senescence by forming 
survivors. DOs - dropouts, i.e. mutants that senesced and were not able to form survivors; est2∆ - 
telomerase-deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant with deleted RAD51;           
est2∆ upf1∆ - telomerase-deficient mutant with inactivated NMD pathway; est2∆ rad51∆ upf1∆ - 
telomerase-deficient mutant with deleted RAD51 and inactivated NMD pathway. 
Mutants Number of DOs % DOs 
est2∆ 0/9 DOs 0 
est2∆ rad51∆ 6/10 DOs 60 
est2∆ upf1∆ 0/10 DOs 0 
est2∆ rad51∆ upf1∆ 16/20 DOs 80 
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Table 9. Single-colony streaking assay performed with mutants of the indicated genotypes, derived from 
the sporulation of AKY2. The mutants were examined for the ability to bypass senescence by forming 
survivors. DOs - dropouts i.e. mutants that senesced and were not able to form survivors; est2∆ - 
telomerase-deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant with deleted RAD51; est2∆ 
upf3∆ - telomerase-deficient mutant with inactivated NMD pathway; est2∆ rad51∆ upf3∆ - telomerase-
deficient mutant with deleted RAD51 and inactivated NMD pathway. 
Mutants Number of DOs % DOs 
est2∆ 0/10 DOs 0 
est2∆ rad51∆ 4/10 DOs 40 
est2∆ upf3∆ 0/10 DOs 0 
est2∆ rad51∆ upf3∆ 17/20 DOs 85 
 
 
3.3. Necessity of UPF2 for type II survivor formation 
Based on the results described in the previous section, it was logical to assume that UPF2 might 
also be required for type II survivor formation. In their work Hu and coworkers (2013) claim that 
type II survivor formation in BY4741 yeast strain background depends on UPF1, UPF2, and 
UPF3. When results of single-colony streaking assay with AKY1 and AKY2 strains were 
gathered, liquid senescence assay was performed with AKY7 strain. This strain was tetrad 
dissected and mutants were identified, some of which were selected and used for liquid 
senescence assay.  The assay was performed according to the instructions described in section 
2.7.  
Data acquired from the assay was processed and results were presented in the form of a graph, as 
shown in Figure 8. The x- and y-axes correspond to the number of population doublings (PDs) 
and to the cell density respectively. Cell density changes in the cultures of single (est2Δ), double 
(est2Δ rad51Δ and est2Δ upf2Δ), triple (est2Δ rad51Δ upf2Δ) mutants and two controls (WT and 
upf2Δ) were entered into the graph. Four cultures of each mutant and two cultures of each control 
were prepared and monitored during the assay. In the end, results for all the cultures of a given 
mutant or control were represented by a single function on the graph.  
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As it can be seen from Figure 8, the growth functions representing the controls did not show any 
significant fluctuations. In other words, there was no significant increase or decrease in the cell 
density, which means that WT and upf2Δ cells did not senesce but continued to grow in the 
cultures until they consumed all of the nutrients required for further growth. This was expected of 
both the controls, since telomerase was active. Functions representing est2Δ and est2Δ rad51Δ 
mutants started increasing with only a few PDs and later on they reached a plateau. Most likely, 
these mutants started senescing before the beginning of the liquid senescence assay so the 
senescing phenotype was not observed. Soon after the beginning of the assay, the cell density of 
these mutants started increasing due to survivor formation. The plateau phase was reached when 
a sufficient amount of nutrients was no longer available in the culture to initiate further cell 
growth. In the case of est2Δ upf2Δ mutants, cell density first started to slowly decrease and then 
continued to slowly increase. This mutant showed less severe senescing phenotype than was to be 
expected. Survivor formation happened later than in the case of the other mutants. As a result, the 
increase in cell density happened later in the assay. The most surprising result was the one for 
est2Δ rad51Δ upf2Δ mutant. This mutant showed a severely senescing phenotype and in the end 
cell density rose due to survivor formation. The type of the formed survivors was not verified 
with Southern blot but since these mutants should not be able to form type I survivors (due to 
RAD51 deletion), a reasonable assumption was that the formed survivors were type II. This result 
contradicts the one reported by Hu and associates (2013), who claim that functional UPF2 is 
required for type II survivor formation in BY4741 yeast strain background.  
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Figure 8. Type II survivor formation does not depend on UPF2. Growth rates were measured in liquid 
culture by serial passaging of haploid meiotic progeny of the indicated genotypes, derived from the 
sporulation of AKY7. est2∆ - telomerase-deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant 
with deleted RAD51; est2∆ upf1∆ - telomerase-deficient mutant with inactivated NMD pathway;        
est2∆ rad51∆ upf1∆ - telomerase-deficient mutant with deleted RAD51 and inactivated NMD pathway;           
WT - wild type; upf2Δ - mutant with inactivated NMD pathway. 
 
3.4. The influence of EBS1 deletion on the occurrence of type II survivors 
Although the specific function of EBS1 is still unknown, it is believed that it codes for a global 
inhibitor of translation. Ford and coworkers (2006) claim that EBS1 inhibits the expression of 
many yeast genes, including ones controlling telomere length. Their results also suggest that 
overexpressing EBS1 reduces gene expression without commensurate changes in transcript 
abundance, which distinguishes EBS1 from UPF genes.  
In addition to UPF1 and UPF3, I tested whether EBS1 is necessary for type II survivor 
formation. The reason for including EBS1 in this study is its connection to NMD. Although EBS1 
is not required for NMD, the connection is evident in the fact that NMD factors interact with 
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translation machinery and in that the levels of EBS1 mRNA are controlled by NMD pathway 
(Ford et al., 2006). Furthermore, it has been demonstrated that EBS1 deletion leads to a slight but 
highly reproducible stabilization of NMD targets (Luke et al., 2007).  
In order to assess the importance of EBS1 for type II survivor formation, I constructed AKY8 
strain. Following tetrad dissection, single, double and triple mutants were identified. Several 
mutant colonies were selected and used in single-colony streaking assay (10 different colonies in 
the case of single and double mutants and 20 in the case of triple mutant). When the assay was 
completed, the amount of mutants that senesced and did not form survivors was determined 
(Table 10). As expected, no est2∆ DOs were observed. On the other hand, as was the case with 
AKY1 and AKY2 strain, the percentage of est2Δ rad51Δ DOs was 40% and thereby higher than 
was expected. est2∆ ebs1∆ mutants formed survivors on almost all of the plates, except for one 
mutant. All but the one mutant most likely formed type I survivors since this survivor type is 
generally found more frequently on solid-medium-grown cultures than type II. Nevertheless, 
since it seems that deletion of EBS1 does not completely block type II survivor formation, it is 
possible that type II survivors also formed on plates with est2∆ ebs1∆ mutants. In the case of 
triple mutant, the percentage of DOs was as high as 75%, which was almost twice as high as in 
the case of est2Δ rad51Δ mutant. This noticeable difference in the percentage of DOs indicates 
that EBS1 might be involved in type II survivor formation.  
Table 10. Single-colony streaking assay performed with mutants of the indicated genotype, derived from 
the sporulation of AKY8. The mutants were examined for the ability to bypass senescence by forming 
survivors. DOs - dropouts, i.e. mutants that senesced and were not able to form survivors; est2∆ - 
telomerase-deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant with deleted RAD51;           
est2∆ ebs1∆ - telomerase-deficient mutant with deleted EBS1; est2∆ rad51∆ ebs1∆ - telomerase-deficient 
mutant with deleted RAD51 and EBS1. 
Mutants Number of DOs % DOs 
est2∆ 0/10 DOs 0 
est2∆ rad51∆ 4/10 DOs 40 
est2∆ ebs1∆ 1/10 DOs 10 
est2∆ rad51∆ ebs1∆ 15/20 DOs 75 
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3.5. Effects of STN1 overexpression on type II survivor formation 
3.5.1 Credibility of STN1 overexpression with GALpr  
Because GALpr was integrated in front of STN1, the expression of this gene depended on the 
presence of galactose. We wanted to examine how STN1 regulation with GALpr would influence 
the growth phenotype of mutants which were grown with or without galactose.  In order to do 
that, tetrad dissection was performed with AKY4 strain. WT and GALpr-STN1 mutant were 
selected and used for single-colony streaking assay. They were streaked both on YPD and YPGal 
plates and later on the growth phenotype was examined. Because of regulation by GALpr, the 
expression of STN1 had to be confined only to the cells growing on YPGal plates. With STN1 
being an essential gene, GALpr-STN1 mutants could not be expected to grow on YPD plates 
when Stn1 was not produced. Surprisingly, as can be seen from the plates presented in Figure 9, 
many colonies of this mutant formed on YPD plates. Although GALpr-STN1 colonies were less 
abundant than WT colonies on YPD plate, they were still present in high numbers. The most 
probable explanation for this observation is that GALpr was leaky so that a certain amount of 
Stn1 was translated. Since STN1 was expressed on YPGal plates GALpr-STN1 mutants were able 
to grow no worse than WT on those plates. This can be seen from Figure 9, which shows that the 
density of WT and GALpr-STN1 colonies grown on YPGal was similar and that WT cells grew 
equally well on YPD and YPGal plates. 
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Figure 9. Single-colony streaking assay performed with WT and GALpr-STN1 mutant. Growth phenotype 
of GALpr-STN1 mutant grown on YPD plate differs from the other three. The fact that some colonies 
have grown indicates that GALpr is leaky. WT - wild type; GALpr-STN1 - mutant with STN1 expression 
controlled by GALpr. 
 
3.5.2 Single-colony streaking assay with AKY3 and AKY4 
Several assays were performed in order to determine whether the rise in the concentration of Stn1 
would result in an inability of yeast cells to form type II survivors. One of them was single-
colony streaking assay performed with AKY3 and AKY4. In these strains the expression of STN1 
was controlled with CUpr and GALpr respectively. As described in section 2.6., single, double 
and triple mutants of each strain were streaked both on YPD and either YPD+Cu or YPGal 
plates. In this way, the growth phenotype of mutants with and without STN1 overexpression was 
monitored. When the assay was completed, DOs of each mutant were counted. Genotypes of the 
streaked mutants and percentage of DOs are shown in Table 11 (for AKY4) and Table 12 (for 
AKY3). 
With respect to both strains the obtained results were not completely clear. With AKY4 strain, 
single mutants were able to form survivors and no DOs were present, just as it had been 
expected. Regarding est2∆ rad51∆ mutants, a high percentage of DOs was observed, just as was 
WT GALpr-STN1 
YPD 
YPGal 
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the case in the single-colony streaking assays described in 3.2. and 3.4. It may have happened 
that random colonies with no survivor cells were picked, which would account for the high 
number of DOs. Results were even more surprising in the case of est2∆ GALpr-STN1 mutant. In 
accordance with the generally held belief, this mutant was expected to form type I survivor cells. 
In case that type II survivors would also be formed, the hypothesis about NMD regulating type II 
survivor formation through STN1 would not be confirmed. Contrary to the expectation about 
survivor formation, the percentage of DOs on YPGal plates was as high as 80%. The observed 
result might suggest that STN1 blocks both type I and type II survivor formation. The percentage 
of DOs on YPD plates was 60 %. With STN1 being an essential gene, est2∆ GALpr-STN1 mutant 
should not have been able to grow on YPD plates since STN1 was not expressed. Also 
unexpectedly no DOs of rad51∆ GALpr-STN1 mutant were observed on YPD plates, most likely 
due to the leakiness of GALpr. Results for triple mutants indicated that upregulation of STN1 
expression resulted in the inability of cells to form type II survivors. The main argument for this 
was the percentage of DOs, which was higher for the mutants grown on YPGal than for the 
mutants grown on YPD. Nevertheless, other results, especially the one for est2∆ GALpr-STN1 
mutant, did not support this claim. It was puzzling that the percentage of est2∆ GALpr-STN1 
DOs (80%) was higher than the one for triple mutants (75%). Even if there is no connection 
between STN1 expression and type II survivor formation, fewer DOs should have been observed 
in the case of est2∆ GALpr-STN1 mutant, since this mutant should generally be able to form type 
I survivors.  
 
 
 
 
 
 
 
34 
 
Table 11. Single-colony streaking assay performed with mutants of the indicated genotype, derived from 
the sporulation of AKY4. Telomerase-deficient mutants were examined for the ability to bypass 
senescence by forming survivors. rad51∆ GALpr-STN1 mutant with functional telomerase is used as a 
control. DOs - dropouts, i.e. mutants that senesced and were not able to form survivors;  est2∆ - 
telomerase-deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant with deleted RAD51;           
est2∆ GALpr-STN1 - telomerase-deficient mutant with STN1 expression controlled by GALpr;        
rad51∆ GALpr-STN1 - mutant with deleted RAD51 and STN1 expression controlled by GALpr;         
est2∆ rad51∆ GALpr-STN1 - telomerase-deficient mutant with deleted RAD51 and STN1 expression 
controlled by GALpr. 
 
YPD YPGal 
Mutants Number of DOs % DOs Number of DOs % DOs 
est2∆ 0/10 DOs 0 0/10 DOs 0 
est2∆ rad51∆ 3/10 DOs 30 1/8 DOs 12.5 
est2∆ GALpr-STN1 6/10 DOs 60 8/10 DOs 80 
rad51∆ GALpr-STN1 0/10 DOs 0 0/10 DOs 0 
est2∆ rad51∆ GALpr-STN1 5/20 DOs 25 15/20 DOs 75 
 
Results for AKY3 strain also did not clearly indicate that overexpression of STN1 was associated 
with the inability of yeast cells to form type II survivors. The same mutants were streaked as in 
the case of AKY4, the only difference being that mutants were streaked on YPD+Cu, instead of 
YPGal plates. Single mutants formed survivors as expected and no DOs were observed. No DOs 
of est2∆ rad51∆ mutant were seen on YPD plates, but once again DOs were present on YPD+Cu 
plates. The difference in the DO presence on YPD and YPD+CU plates was puzzling because 
this mutant should be able to form type II survivors on both types of plates. In the case of est2∆ 
CUpr-STN1, no DOs were present on either of the plates. Although STN1 should not be 
expressed in mutants grown on YPD plates, the observed result was as expected since CUpr is 
known to be leaky. Most likely, CUpr was leaky thus allowing the production of a certain amount 
of Stn1. In rad51∆ CUpr-STN1 mutant telomerase was active so the percentage of DOs was equal 
to 0. The observed increase in the percentage of triple mutant DOs correlated with the higher 
expression of STN1. Unfortunately, as was the case with the results for AKY4 strain, other results 
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(particularly the one for est2∆ rad51∆ mutant) made it impossible to conclude whether 
overexpression of STN1 prohibited type II survivor formation. 
Table 12. Single-colony streaking assay performed with mutants of indicated genotype, derived from the 
sporulation of AKY3. Telomerase-deficient mutants were examined for the ability to bypass senescence 
by survivor formation. rad51∆ GALpr-STN1 mutant with functional telomerase is used as a control.     
DOs - dropouts, i.e. mutants that senesced and were not able to form survivors; est2∆ - telomerase-
deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant with deleted RAD51; est2∆ CUpr-STN1 - 
telomerase-deficient mutant with STN1 expression controlled by CUpr; rad51∆ CUpr-STN1 - mutant with 
deleted RAD51 and STN1 expression controlled by CUpr; est2∆ rad51∆ CUpr-STN1 - telomerase-
deficient mutant with deleted RAD51 and STN1 expression controlled by CUpr. 
 YPD YPD+Copper 
Mutants Number of DOs % DOs Number of DOs % DOs 
est2∆ 0/10 DOs 0 0/10 DOs 0 
est2∆ rad51∆ 0/6 DOs 0 5/8 DOs 62.5 
est2∆ CUpr-STN1 0/10 DOs 0 0/10 DOs 0 
rad51∆ CUpr-STN1 0/10 DOs 0 0/10 DOs 0 
est2∆ rad51∆ CUpr-STN1 3/8 DOs 37.5 8/13 DOs 61.5 
 
3.5.3 Liquid senescence assay with AKY4 strain 
The effect of STN1 overexpression on type II survivor formation was also examined with liquid 
senescence assay. As opposed to single-colony streaking assay, senescence assay in liquid 
cultures enables control over additional conditions that could otherwise influence the final 
outcome of the assay. After tetrad dissection, the following mutants were identified and used in 
liquid senescence assay: single (est2∆), double (est2∆ rad51∆ and est2∆ GALpr-STN1) and triple 
(est2∆ rad51∆ GALpr-STN1) mutants. Four cultures of each of the mutants were grown at the 
beginning of the assay. Along with these mutants, WT and GALpr-STN1 controls were also 
included in the study. Two cultures of every control were prepared.  
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In total, cell density of 18 different cultures was measured each day for 10 days. Results were 
entered into a graph (Figure 10), with the x-axis corresponding to the number of PDs and the     
y-axis corresponding to the cell density. Each function represents all of the cultures of a 
particular mutant or control. The functions of controls did not show any major changes in the 
cultures’ cell density. It was noticed that overexpression of STN1 had a slightly negative effect on 
cell growth, because WT grew better and reached higher density values than GALpr-STN1. All of 
the other functions, which described the growth of est2∆, est2Δ rad51Δ, est2Δ GALpr-STN1 and 
est2Δ rad51Δ GALpr-STN1 mutants, could be divided into three different phases. The first phase 
represented the decrease in cell density as a consequence of the mutants entering replicative 
senescence due to telomerase deficiency. After the critical point was reached (the point of the 
lowest cell density on the graph), survivors formed in all of the cultures and cell density started to 
rise. The second phase included a progressive rise in cell density, accompanied by survivors 
overtaking the cultures. The last phase was the plateau phase, in which no or very small changes 
in cell density were observed. The plateau phase was reached because survivors kept dividing 
until the cultures no longer contained enough nutrients to sustain the growth of additional 
survivors. It can be seen from the graph that survivors formed a bit later in the case of est2Δ 
mutant. Also the first phase lasted longer in the case of est2Δ than with the other mutants. All of 
the functions eventually reached a plateau, indicating a similar maximum cell density value for 
all mutants. Most importantly, the results of this assay suggested that all the mutants were able to 
form survivors. The results for est2Δ, est2Δ rad51Δ, est2Δ GALpr-STN1mutants turned out as 
was expected. The result for est2Δ rad51Δ GALpr-STN1 was quite interesting since it suggested 
that overexpression of STN1 was not linked to inability of cells to form type II survivors. In order 
to confirm these results, the type of survivors was validated with Southern blot.  
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Figure 10. STN1 overexpression does not prevent type II survivor formation. Growth rates were monitored 
in liquid culture by serial passaging of haploid meiotic progeny of the indicated genotypes, derived from 
the sporulation of AKY4. est2∆ - telomerase-deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant 
with deleted RAD51; est2∆ GALpr-STN1 - telomerase-deficient mutant with STN1 expression controlled 
by GALpr; est2∆ rad51∆ GALpr-STN1 - telomerase-deficient mutant with deleted RAD51 and STN1 
expression controlled by GALpr; WT - wild type; GALpr-STN1- mutant with STN1 expression controlled 
by GALpr . 
 
3.5.4 Telomere Southern blot of AKY4 strain mutants 
By performing a telomere Southern blot, it is possible to determine whether survivors are type I 
or II. Samples taken from liquid senescence assay cultures that were collected on day 0 and day 9 
were used for Southern blot. These particular samples were used because they represented the 
starting point and the end point of liquid senescence assay, reflecting the overall changes in 
cultures accumulated during the assay. It was expected that on day 0 there would be no survivors, 
while on day 9 survivors would have overtaken the cultures. gDNA was isolated from the day 0 
and day 9 samples and digested O/N with XhoI. Telomere Southern blot was performed 
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according to the procedure described in section 2.8. A picture of the developed membrane is 
given in Figure 11. Samples taken on days 0 and 9 originating from the same mutant culture were 
positioned adjacent to each other. For the controls, only samples taken from one culture were 
analyzed. In contrast, samples taken from two different cultures in the case of est2Δ and est2Δ 
rad51Δ mutants and four different cultures in the case of est2Δ GALpr-STN1 and est2Δ rad51Δ 
GALpr-STN1 mutant were analyzed. The loaded amount of DNA was the same for all of the 
samples. 
In the case of GALpr and WT controls, survivors were not present in the cultures. Bands 
corresponding to the sample taken on day 0 were slightly weaker than the bands corresponding to 
the samples from day 9. This was probably due to slower growth of cells, which had to adapt to 
new conditions in liquid cultures.  
Survivor formation was not detected in day 0 samples of est2Δ mutant. Results for the day 9 
samples of est2Δ mutant indicated that type II survivors were present in the cultures even if this 
mutant should have been able to form both types of survivor. The reason why type II and not type 
I survivors were detected in the sample had to do with the ability of type II survivors to grow at 
faster rates than type I.  
As was the case with the controls and est2Δ mutant, no survivor formation was detected in day 0 
samples of est2Δ rad51Δ mutant. As mentioned before, est2Δ rad51Δ mutant should be able to 
form only type II survivors. Indeed, the band pattern suggesting type II survivor formation was 
observed in both day 9 samples.  
All of the samples of est2Δ GALpr-STN1 mutant were organized in one sequence, with the 
samples from one and the same culture adjacent to each other. The sample taken on day 0 from 
the first culture on the left was excluded from the assay because the concentration of DNA was 
too low for it to be successfully detected. While survivors were not detected in any day 0 sample, 
type II survivors formed in all of the day 9 samples. This result suggested that mutants in which 
STN1 was overexpressed could form type II survivors. est2Δ GALpr-STN1 should have been able 
to form type I survivors as well. Type I survivors had probably formed in the culture earlier than 
type II but at some point during the assay type II survivors overtook the culture. 
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The results for est2Δ rad51Δ GALpr-STN1 mutant were similar to the ones obtained for est2Δ 
GALpr-STN1 mutant. While survivor presence could not be clearly seen in day 0 samples, type II 
survivors were detected in all of the day 9 samples. This result, together with the one for est2Δ 
GALpr-STN1 mutant, showed that mutants with STN1 overexpression were capable of forming 
type II survivors. 
 
  
 
                
Figure 11. Telomere Southern blot performed with samples from days 0 and 9 of cultures grown in YPGal 
from liquid senescence assay (cf. section 3.5.3). Type of the formed survivors was determined according 
to the band pattern. Type I survivors exhibit strong hybridization at 5.2 kb and 6.7 kb, due to the 
amplification of the subtelomeric Y’ elements. Type II survivors exhibit hybridization at many positions 
due to the diverse lengths of their terminal fragments. These fragments consist of TG1-3 telomeric repeats, 
which are amplified in type II survivors. GALpr-STN1- mutant with STN1 expression controlled by 
GALpr; WT - wild type; est2∆ - telomerase-deficient mutant; est2∆ rad51∆ - telomerase-deficient mutant 
with deleted RAD51; est2∆ GALpr-STN1 - telomerase-deficient mutant with STN1 expression controlled 
by GALpr; est2∆ rad51∆ GALpr-STN1 - telomerase-deficient mutant with deleted RAD51 and STN1 
expression controlled by GALpr.  
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The fact that the mutants in which STN1 was overexpressed were able to form type II survivors 
did not necessarily exclude the possibility of high concentrations of Stn1 disrupting the genesis of 
these survivors. Based on the results presented here it was clear that STN1 overexpression could 
not completely block type II survivor formation but it could have still interfered with the events 
leading to generation of this type of survivor. In other words, STN1 overexpression might have 
blocked type II survivor formation to a certain degree, allowing sporadic successful formation. In 
that respect, it is possible that the detected type II survivors (in the case of est2Δ GALpr-STN1 
and of est2Δ rad51Δ GALpr-STN1 mutants) all originated from a small number of initially 
formed type II survivor cells. Since the samples in which type II survivors were detected were 
gathered 9 days after the beginning of the assay, even a small number of type II survivors would 
have had enough time to overtake the cultures. 
In order to confirm this hypothesis, another telomere Southern blot was performed (Figure 12). 
This time, day 9 samples were replaced with samples in which survivor formation was first 
detected. These samples were taken at the point in time when cell density started increasing due 
to survivor formation. Survivors present in these samples were referred to as “early survivors”. 
Day 0 samples were excluded from this analysis. In the case of controls, the same principle could 
not be followed since survivor formation did not take place. Day 5 samples were then selected for 
analysis since most samples from other mutants were taken on the fifth day. Samples of controls 
and mutants were arranged on the membrane in the same order as on the previous one.           
In the case of the controls, several additional bands could be observed along with the ones 
corresponding to the length of 5.5 kb or 6.5 kb. These bands represented the telomeres which did 
not contain Y’ subtelomeric elements.  
Two est2Δ mutant samples were analyzed and it was determined that type II survivors were 
predominant in one sample, while type I were in the other. This result suggested that type I 
survivors were indeed formed in the culture, which was soon after overtaken with type II 
survivors. Furthermore, type II survivors were detected in all of the other samples which 
suggested that type II survivors were formed early in the culture. This type of survivor was 
present in est2Δ GALpr-STN1 and est2Δ rad51Δ GALpr-STN1 cultures soon after the increase in 
cell density was observed. Thus, it was unlikely that the type II survivors detected at day 9 
originated from a small number of initially formed survivors. These results showed that type II 
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survivor formation was not severely affected by STN1 overexpression. Nevertheless, the 
possibility of excess Stn1 partially disturbing the events leading to genesis of this type of 
survivor could not be completely rejected.  
 
 
 
            
Figure 12. Telomere Southern blot performed with samples of cultures grown in YPGal from liquid 
senescence assay (cf. section 3.5.3). A majority of samples were gathered on day 5 or day 6, representing 
the time point at which early survivors were formed. Type I survivors exhibit strong hybridization at      
5.2 kb and 6.7 kb, due to the amplification of the subtelomeric Y’ elements. Type II survivors exhibit 
hybridization at many positions due to the diverse lengths of their terminal fragments. These fragments 
consist of TG1-3 telomeric repeats, which are amplified in type II survivors. 1 - GALpr-STN1; 2 - WT;      
3 - est2Δ; 4 - est2Δ rad51Δ; 5 - est2Δ GALpr-STN1; 6 - est2Δ rad51Δ GALpr-STN1. 
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3.5.5 Effect of STN1 overexpression on telomere length 
It has been reported in the literature that telomeres are maintained at shorter length in mutants 
with STN1 overexpression. Dahlseid and coworkers (2002) showed that STN1 overexpression 
reduced telomere length to the same extent as was observed for NMD mutants.  
This assay investigated whether STN1 overexpression with GALpr would have an impact on 
telomere length. In order to do so, telomere length of WT and GALpr-STN1 mutant was analyzed 
with telomere Southern blot and the respective results were compared to each other. Prior to 
Southern blot analysis, tetrad dissection was performed and haploid WT and GALpr-STN1 
colonies were identified. WT and GALpr-STN1 cultures were grown O/N in YPD and YPGal at 
30oC. The next day gDNA was isolated and digested O/N with XhoI. Telomere Southern blot was 
performed according to the protocol described in section 2.8. Results are shown in Figure 13. It 
can be seen in the picture that the band pattern and the signal strength were similar for all of the 
samples. In addition, bands representing telomere terminal fragments (1-1.3 kb) were very much 
alike, suggesting that STN1 overexpression is not associated with shorter telomere phenotype. 
Such a result does not correspond to those published in the literature or to the proposed function 
of Stn1 in inhibiting telomerase recruitment at telomeres. A possible explanation of the observed 
result is that the performed assay was not sensitive enough to detect small changes in telomere 
length between WT and GALpr-STN1 mutant. Another explanation could be that STN1 was not 
as strongly overexpressed as in the other studies. If that was the case, maybe the change in 
telomere length could not be detected or not enough time passed for additional Stn1 to have an 
impact on it. 
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Figure 13. Telomere Southern blot of WT and GALpr-STN1 mutant grown in YPD and YPGal. The bands 
between 1-1.3 kb represent terminal telomere fragments. These fragments contain TG1-3 repeats that are 
elongated by the action of telomerase. In the case of both WT and GALpr-STN1 mutants terminal 
telomere fragments are of similar size, suggesting that telomeres are not maintained at shorter length when 
STN1 is overexpressed. WT - wild type; GALpr-STN1- mutant with STN1 expression controlled by 
GALpr. 
 
3.6. Impact of RAD51 overexpression on survivor formation 
As mentioned in section 1.1, NMD is not strictly confined to the mRNA bearing a premature 
termination codon. Aside from controlling the levels of telomere related proteins, NMD plays a 
direct role in regulation of HR. Janke and associates (2016) reported that mRNA levels of 
RAD51, RAD54, RAD55 and RAD57 are regulated by NMD. As previously described in section 
1.3., RAD51 is involved in type I survivor formation while it is not required for the generation of 
type II survivors. Overexpression of RAD51 may thus result in more frequent type I survivor 
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formation. If Rad51 is present in relatively high quantities, the balance between occurrences of 
type I and type II survivors could shift toward type I. As a result, the generation of type II 
survivors could prove rare or even not possible. In order to test this hypothesis, AKY5 and AKY6 
strains were constructed. Tetrad dissection enabled the identification of mutants that would later 
be used for single-colony streaking assay. In the assay, mutants of interest were streaked both on 
YPD and YPGal plates. Results of single-colony streaking assay for AKY5 strain are shown in 
Table 13 and for AKY6 strain in Table 14.  
As can be seen from the tables, all of the mutants were successful in survivor formation. This 
indicates that RAD51 overexpression did not interfere with events leading toward survivor 
formation. The percentage of DOs was higher than 0 only in the case of est2∆ GALpr-RAD51 
mutant grown on YPD plates. A possible explanation for the observed number of DOs is that 
colonies that did not contain survivors were picked and streaked.  
Table 13. Single-colony streaking assay performed with mutants of the indicated genotype, derived from 
the sporulation of AKY5. Telomerase-deficient mutants were examined for the ability to bypass 
senescence by forming survivors. GALpr-RAD51 mutant with functional telomerase is used as a control. 
DOs - dropouts, i.e. mutants that senesced and were not able to form survivors; est2∆ - telomerase-
deficient mutant; GALpr-RAD51 - mutant with RAD51 expression controlled by GALpr;                      
est2∆ GALpr-RAD51 - telomerase-deficient mutant with RAD51 expression controlled by GALpr. 
 
YPD YPGal 
Mutants Number of DOs % DOs Number of DOs % DOs 
est2∆ 0/10 DOs 0 0/9 DOs 0 
GALpr-RAD51 0/10 DOs 0 0/10 DOs 0 
est2∆ GALpr-RAD51 2/10 DOs 20 0/10 DOs 0 
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Table 14. Single-colony streaking assay performed with mutants of the indicated genotype, derived from 
the sporulation of AKY6. Telomerase-deficient mutants were examined for the ability to bypass 
senescence by forming survivors. GALpr-RAD51 mutant with functional telomerase is used as a control. 
DOs - dropouts, i.e. mutants that senesced and were not able to form survivors; tlc1∆ - telomerase-
deficient mutant; GALpr-RAD51 - mutant with RAD51 expression controlled by GALpr;                             
tlc1∆ GALpr-RAD51 - telomerase-deficient mutant with RAD51 expression controlled by GALpr. 
 
YPD YPGal 
Mutants Number of DOs % DOs Number of DOs % DOs 
tlc1∆ 0/5 DOs 0 0/5 DOs 0 
GALpr-RAD51 0/5 DOs 0 0/5 DOs 0 
tlc1∆ GALpr-RAD51 0/10 DOs 0 0/10 DOs 0 
 
Survivor colonies of est2∆ GALpr-RAD51 mutant that formed in the single-colony streaking 
assay just described were further analyzed. Seven early survivor colonies (formed immediately 
after the cells started senescing) were taken from both YPD and YPGal plates and grown for 16 
hours in 2.5 ml of YPD and YPGal medium respectively. gDNA was then isolated from samples 
of all the cultures and digested O/N with XhoI. Digested gDNA was further analyzed with 
telomere Southern blot, results of which are shown in Figure 14. gDNA of est2∆ GALpr-RAD51 
mutants that had been grown on YPD plates were loaded into lanes 2-8 and that of                 
est2∆ GALpr-RAD51mutants that had been grown on YPGal plates into lanes 9-15. Results 
indicated that mutants without RAD51 overexpression (i.e. the ones grown on YPD) were able to 
form type II survivors, while mutants in which RAD51 was overexpressed (i.e. the ones grown on 
YPGal) formed type I survivors. This result was expected: in mutants grown on YPD plates 
transcription of RAD51 was shut down so survivors generated were type II. In est2∆ GALpr-
RAD51 mutant grown on YPGal, RAD51 was expressed and type I survivor formation was thus 
allowed. Type II survivors were not detected in the mutant grown on YPGal most likely because 
16 hour incubation in liquid media did not allow enough time for type II survivors to suddenly 
form and to take over the culture. It is also possible that the conditions of higher Rad51 
concentrations favored type I survivor formation, while not being involved in blocking the 
formation of type II survivors. 
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Figure 14. Telomere Southern blot of est2∆GALpr-RAD51 survivors grown in YPD or YPGal. Type I 
survivors exhibit strong hybridization at 5.2 kb and 6.7 kb, due to the amplification of the subtelomeric Y’ 
elements. Type II survivors exhibit hybridization at many positions due to the diverse lengths of their 
terminal fragments. These fragments consist of the TG1-3 telomeric repeats, which are amplified in type II 
survivors. est2∆ GALpr-RAD51 - telomerase-deficient mutant with RAD51 expression controlled by 
GALpr. 
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4. Discussion  
The connection between NMD and survivor formation in S. cerevisiae was first established when 
Hu and coworkers (2013) showed that UPF1, UPF2, UPF3 and EBS1 are required for type II 
survivor formation. The study presented here tested whether mutants in which either UPF1, 
UPF2, UPF3 or EBS1 was deleted would be able to generate type II survivors and then evaluated 
exactly how NMD would influence type II survivor formation. 
 
Single-colony streaking assays with AKY1, AKY2 and AKY8 strains were performed. With all 
the three strains, the percentage of DOs was highest for triple mutants, suggesting that UPF1, 
UPF3 and EBS1 were required for type II survivor formation. On the other hand, 20% of est2∆ 
rad51∆ upf1∆, 15% of est2∆ rad51∆ upf3∆ and 25% of est2∆ rad51∆ ebs1∆ mutant were able to 
form survivors. Since RAD51 was deleted in these mutants, it is highly probable that the formed 
survivors were type II, but telomere Southern blot would have to be performed in future studies 
to prove this. If the assumption regarding the survivor type is correct, it is logical to assume that 
deletion of UPF1, UPF3 and EBS1 does not completely block the formation of this type of 
survivors. The results for UPF1 and UPF3 could therefore imply that UPF2 does not have a 
specific function in type II survivor formation and that there is a connection between this process 
and NMD. However, an earlier study in Dr. Chang’s laboratory (unpublished data) and a study by 
Hu and coworkers (2013) suggested that upf2Δ mutants were completely incapable of type II 
survivor formation. At present, I cannot explain this discrepancy and further studies are needed to 
address this issue. Another point that should be addressed is to what extent the deletion of UPF1, 
UPF3 and EBS1 affects the generation of type II survivors. Observations from single-colony 
streaking assays made in this study should be confirmed and further explored with liquid 
senescence assays followed by telomere Southern blots. These assays could provide additional 
information about the efficiency and frequency of type II survivor formation. Also, by analyzing 
samples gathered on different days during liquid senescence assay, the time point at which type II 
survivors form could be determined. By doing so, it could be established whether deletion of 
UPF1, UPF3 and EBS1 disturbs the generation of type II survivors and to what extent.  
The results from single-colony streaking assay applying to est2∆, est2∆ upf1∆, est2∆ upf2∆ and 
est2∆ ebs1∆ were as expected, with no DOs or only one DO in the case of est2∆ ebs1∆ mutant. 
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Surprisingly, the same was not true of the est2∆ rad51∆ mutant. Although this mutant should 
have been able to form type II survivors, the percentage of DOs was 60 % (for AKY1) and 40 % 
(for AKY2 and AKY8). If one takes into account that type II survivors occur less frequently than 
type I on solid-medium-grown cultures, it is justified to assume that type II survivor colonies may 
have not been picked and restreaked during single-colony streaking assay. As a result, it seemed 
as if many est2∆ rad51∆ mutants were not able to overcome senescence. This assumption is 
substantiated by the fact that a considerable number of est2∆ rad51∆ DOs were observed in the 
majority of single-colony streaking assays performed in this study and earlier in Dr. Chang’s 
laboratory (unpublished data). Nevertheless, it remains doubtful whether this explanation can 
account for the observed percentages of est2Δ rad51Δ DOs. It is thus also possible that the 
increased number of DOs was linked to deletion of RAD51 in est2∆ background, although the 
existence of this link is uncertain. All in all, although the percentage of est2∆ rad51∆ DOs was 
noticeably high it was still lower than the percentage of triple mutant DOs and thus did not 
exclude the possibility of UPF1, UPF3 and EBS1 being involved in the genesis of type II 
survivors. In order to verify the published data reporting the importance of UPF2 for type II 
survivor formation, liquid senescence assay was performed with AKY7. Unexpectedly, survivor 
formation was detected in all of the cultures of est2Δ rad51Δ upf2Δ mutant. The type of the 
formed survivors was not checked with telomere Southern blot, but since these mutants could not 
form type I survivors, a reasonable assumption was that the formed survivors were of type II. 
Such an outcome counters not only the results reported by Hu and coworkers (2013), but also the 
one obtained in the laboratory of Dr. Chang. Hu and associates grew 280 telomerase-null mutants 
with different single gene deletions serially passaged in a liquid medium in order to screen for 
genes that might affect type II survivor formation. The way in which they performed the assay 
did not significantly differ from the liquid senescence assay described in this study. The main 
difference was that Hu and coworkers worked with BY4741 yeast strain background, while the 
experiments in this study were carried out in W303 strain background. It is not known whether 
type II survivor formation is differently affected when working in one or the other strain 
background. However, even if yeast strain background somehow affected the process in the study 
by Hu et al. (2013), that explanation says nothing about the lack of correspondence between the 
observations made earlier in the Dr. Chang’s laboratory and the ones described in this study. The 
former were based on liquid senescence assay with YPM10 (MATa/α est2::URA3/EST2 
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rad51::natMX4/RAD51 upf2::kanMX4/UPF2). This strain harbored the same gene deletions as 
AKY7. Nevertheless, survivor formation was not detected in the cultures of the est2Δ rad51Δ 
upf2Δ mutant derived from YPM10. Liquid senescence assay in the study reported here was 
performed under same conditions as the earlier one, the only difference being different origin of 
the examined mutants. Both YPM10 and AKY7 were obtained by transforming YPM9, and the 
construction of these strains was checked with PCR. With regard to that, it is puzzling why triple 
mutants from AKY7 were able to form survivors, when the ones from YPM10 were not. To 
elucidate this matter, a new AKY7 strain should be constructed and the liquid senescence assay 
should be repeated with the new strain. 
 
As described in 1.4, we hypothesized that NMD influences type II survivor formation by 
regulating the level of protein(s) important for telomere biology. As it was pointed out, several 
telomere related proteins are regulated by NMD, among them Stn1 and Ten1 (Holstein et al., 
2014). We decided to focus our attention on STN1 since observations reported earlier (cf. section 
1.5.) made it reasonable to assume that STN1 could be the link between NMD and type II 
survivor formation. Two strains were therefore constructed, AKY3 and AKY4, in which 
expression of STN1 was put under the control of CUpr and GALpr respectively. Single-colony 
streaking assay was performed to assess whether STN1 overexpression would interfere with type 
II survivor formation. Unfortunately, neither the results for AKY3 nor those for AKY4 provided 
a clear indication of a connection between STN1 overexpression and the inability of cells to form 
type II survivors. In the case of AKY4, overexpression of STN1 resulted in an increase in the 
number of est2∆ rad51∆ GALpr-STN1 DOs. The DO percentage for the mutant grown on YPD 
was 25% and it was 75% for the mutant grown on YPGal. This observation could be interpreted 
as if the excess Stn1 impaired type II survivor formation but did not completely block it, since 
25% of triple mutants grown on YPGal were able to bypass senescence by forming survivors. 
Nevertheless, other results, especially the one for est2∆ GALpr-STN1 mutant, do not support this 
claim. Surprisingly, the percentage of est2∆ GALpr-STN1 DOs (80%) was higher than the one 
for triple mutants (75%). Since est2∆ GALpr-STN1 mutant should have been able to form type I 
survivors, which was not the case with triple mutant, one would have expected that more DOs 
would be observed in the case of triple mutant. Still, it is unknown whether overexpression of 
STN1 affects type II survivor formation in est2∆ in a different way than in est2∆ rad51∆ 
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background. In addition, the literature does not rule out the possibility of STN1 overexpression 
interfering with type I survivor formation. The high percentage of est2∆ GALpr-STN1 DOs could 
thus be explained by STN1 overexpression affecting type I survivor formation and brings about a 
stricter prohibition of type II survivor generation than in the est2∆ rad51∆ background. On the 
other hand, the results for the est2∆ CUpr-STN1 do not support this view since no DOs of this 
mutant were present on YPD+Cu plates, although this difference may be due to different levels of 
overexpression using the two promoters. 
It could be assumed that the increase in the number of est2∆ rad51∆ CUpr-STN1 DOs was a 
consequence of STN1 overexpression but the result for est2∆ rad51∆ mutant in particular does 
not support such a claim. Since the percentage of DOs was almost the same for est2∆ rad51∆ and 
est2∆ rad51∆ CUpr-STN1 mutant, it is not clear whether overexpression of STN1 disturbed type 
II survivor formation. It is puzzling why the number of est2∆ rad51∆ DOs was so high since this 
mutant should have been able to form type II survivors. It is also unclear why no est2∆ rad51∆ 
DOs were observed on YPD plates, when their composition differs from YPD+Cu plates only in 
that they do not contain copper. As discussed above, one explanation could be that survivor 
colonies were not picked and restreaked during single-colony streaking assay because of the low 
incidence of type II survivor formation on solid-medium-grown cultures.  
With STN1 being an essential gene, est2∆ GALpr-STN1, rad51∆ GALpr-STN1 and est2∆ rad51∆ 
GALpr-STN1 mutants should not have been able to grow on YPD plates since STN1 was not 
expressed. Most likely, GALpr was leaky thus allowing the production of sufficient Stn1 to 
enable the growth of these mutants. The results of the experiment described in section 3.5.1 
support this proposition. As can be seen in Figure 9, GALpr-STN1 mutant was able to grow on 
YPD plate, although less efficiently than on YPGal plate. In the case of AKY3, est2∆ GALpr-
STN1, rad51∆ GALpr-STN1 and est2∆ rad51∆ GALpr-STN1 mutants were also able to grow on 
YPD. Such an observation was expected, since it is known that CUpr is even leakier than GALpr.  
The reason why results of single-colony streaking assays with AKY3 and AKY4 are inconclusive 
may be connected with the way in which such assays are carried out. Although one colony is 
streaked each time, it is very unlikely that all the colonies picked within one assay are of the same 
size. In other words, the amounts of cells transferred to a new section of plates differ. 
Furthermore, the streaked colonies may consist of a varying number of senescing or survivor 
cells or even cells in a different phase of the cell cycle. In addition, telomeres of the cells making 
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up various colonies are not necessarily of the same length. In case that a colony containing cells 
with insufficiently long telomeres is selected, this may result in no colony formation on the new 
section. On the other hand, if a colony with cells having longer telomeres is selected, new 
colonies can form and additional time for survivor cells to emerge is provided. If in the next 
streaking cycle the newly formed survivor colony is picked, this could greatly influence the final 
result of the assay. With this in mind, it is clear that certain conditions cannot be controlled when 
single-colony streaking assay is performed. It is thus possible that the results of the assays in my 
study were influenced by the way they were carried out.   
 
In order to further evaluate the idea that excess Stn1 prevents type II survivor generation, liquid 
senescence assay was performed with AKY4. Results showed that est2Δ, est2Δ rad51Δ, est2Δ 
GALpr-STN1 and est2Δ rad51Δ GALpr-STN1mutants were able to form survivors. All of the 
mutants first started senescing until the critical point was reached and then the cultures were 
“repopulated” with survivor cells. The fact that survivor formation was detected in est2Δ rad51Δ 
GALpr-STN1 mutant cultures suggested that STN1 overexpression does not prevent type II 
survivor formation – the survivors had to be of that type, since this mutant is believed not to be 
able to form type I survivors. This was confirmed with telomere Southern blot. First, Southern 
blot with samples from day 0 and day 9 was performed. The samples were chosen because they 
reflect the overall change that took place during liquid senescence assay. In addition, between the 
first and the last day enough time was provided for type II survivors to form. As expected, 
survivor formation was detected only in day 9 samples. Survivors in the est2Δ and est2Δ rad51Δ 
samples were type II. With the former, type I survivor formation most likely preceded type II 
survivor formation, which overtook the cultures afterwards. The most significant results were the 
ones for est2Δ GALpr-STN1 and est2Δ rad51Δ GALpr-STN1 mutants. Type II survivors were 
detected in all of the day 9 samples of these mutants indicating that the STN1 overexpression did 
not prevent type II survivor formation. Nevertheless, this observation did not exclude the 
possibility that overexpression of STN1 interfered with type II survivor generation. In other 
words, high levels of Stn1 may only partially block formation of these survivors thus limiting the 
likelihood of their generation. As mentioned before, it is thus possible that the detected type II 
survivors (in the case of est2Δ GALpr-STN1 and of est2Δ rad51Δ GALpr-STN1 mutants) all 
originated from a small number of initially formed type II survivor cells. In order to test this, 
52 
 
telomere Southern blot with samples of early survivors was performed. Type II survivor 
formation was detected in both the est2Δ GALpr-STN1 and est2Δ rad51Δ GALpr-STN1 samples, 
suggesting that these survivors were already present in the cultures soon after the observed 
increase in cell density. Since type II survivors were detected in the cultures at this early stage, 
the explanation that the type II survivors detected at day 9 originated from only a small number 
of initially formed survivors does not seem well-founded. It seems thus that STN1 overexpression 
did not significantly disturb type II survivor formation. Still, the hypothesis that STN1 
overexpression blocks the generation of this survivor type to a certain degree was thereby not 
completely disproven. Unfortunately, the limitations of liquid senescence assay render it 
impossible to provide an unequivocal answer to this issue. Even if with this kind of assay more 
conditions can be controlled than with single-colony streaking assay, it still has its limitations. It 
is thus not sensitive enough to exclude the possibility of excess Stn1 partially disturbing 
generation of type II survivors. As described earlier in this section, we tried to prove this 
proposition by specifically analyzing the samples taken at the time point closest to the earliest 
detected survivor formation. Even though these were the first samples gathered after a noticeable 
rise in cell density, they did not necessarily reflect the situation in cultures right after the 
formation of earliest survivors. In other words, the assay in general does not provide the option to 
gather samples immediately after the generation of survivors. Thus, even the early samples that 
were analyzed may not have been adequate to enable us to notice the effects of STN1 
overexpression on the formation of type II survivors. This claim is corroborated by the fact that 
only type II survivors were detected in the early samples of est2Δ GALpr-STN1 mutant. Since 
this mutant should have been able to form type I survivors (which generally arise more frequently 
in cultures than type II), it was expected that these survivors would be the first to form. The fact 
that type I survivors were not detected in any of the est2Δ GALpr-STN1 early samples, suggests 
that enough time had passed for type II survivors to form and overtake the cultures. This 
circumstance would thus support the claim that the samples did not correspond to the time point 
right after the initial survivor formation.  
Another flaw of liquid senescence assay is the inability to secure consistent serial passaging of 
the content containing haploid meiotic progeny. In other words, it is not possible to ensure that 
the transferred samples will contain a corresponding number of viable, senescing and survivor 
cells, which can affect the outcome of the assay. That might also be an explanation why the 
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results of liquid senescence assay were different when performed with YPM10 and AKY4 
strains.   
 
In addition to analyzing the effects of STN1 overexpression on type II survivor formation it was 
worth checking whether overexpression of STN1 with GALpr would bring about a decrease in the 
length at which telomeres were maintained. In order to do so, telomeres of WT and GALpr-STN1 
mutant grown O/N in YPD and YPGal were analyzed. Surprisingly, the obtained result did not 
align with the observations described by Dahlseid and coworkers (2002) about STN1 
overexpression reducing telomere length to the same extent as was observed for NMD mutants. 
The length of telomere terminal fragments was much the same in the case of both the WT and 
GALpr-STN1 mutant grown in YPD and YPGal. Such a result suggests that overexpression of 
STN1 does not cause short telomere phenotype, which would also contradict the proposed role of 
Stn1 as a negative regulator of telomerase (Grandin et al., 2000). The fact that the expected 
phenotype was not observed can be explained by one of the following circumstances. First, the 
performed telomere Southern blot analysis might not have been sensitive enough to distinguish 
small differences in the length of telomere fragments. Dahlseid et al. (2002) describe that the 
length of the 0.8 kb long terminal telomere fragment was ~43+ /- 19 bp shorter in mutants with 
STN1 overexpression compared to WT. The Southern blot performed in this study may have 
failed to spot such small changes even if they were actually present. Such changes in telomere 
length could be detected by telomere PCR. Secondly, the concentration of cellular Stn1 in 
GALpr-STN1 mutant might not have been high enough to cause the expected phenotype. Since 
GALpr-STN1 construct is uncharacterized, the exact degree of STN1 overexpression remains to 
be determined. In their work, Dahlseid et al. (2002) used yeast 2 µm vectors containing multiple 
copies of STN1 with its native promoter. It is possible that the levels of mRNA, as well as Stn1, 
were higher in cells transformed with 2 µm vectors compared to the ones with an integrated 
GALpr-STN1 construct. In other words, overexpression of STN1 with GALpr might not be strong 
enough to cause the maintenance of telomeres at a shorter length than in WT. If the levels of 
STN1 expressions indeed were different in the two studies, more time could have been required 
for Stn1 to confer its effect on telomere phenotype in AKY4. The difference in the length of 
telomere terminal fragments might thus have been more perceptible if the incubation time of WT 
and GALpr-STN1 mutant cultures had been increased. 
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In future work it should be determined how much the steady-state of Stn1 increases in mutants 
containing GALpr-STN1 construct. It would also be necessary to find out whether Stn1 level 
increase in these mutants generally equals or exceeds the magnitude of the Stn1 increase in upfΔ 
mutants. This can be done by performing northern blot analysis and establishing whether the 
levels of STN1 mRNA are increased in GALpr-STN1 mutants. Another approach may be to 
measure and compare the change in Stn1 concentration in GALpr-STN1 and in upfΔ mutants. 
This can be achieved by creating a construct in which STN1 is fused with a certain tag sequence.  
The difference in Stn1 levels in mutants of interest could be determined by Western blot analysis.  
 
Aside from controlling the levels of telomere related proteins, NMD plays a direct role in 
regulation of HR. It is therefore possible that NMD regulates type II survivor formation not 
through regulation of a certain telomere related protein but by affecting the levels of a specific 
protein involved in HR events that lead to survivor formation. One of the HR genes controlled by 
NMD is RAD51, whose role as a potential link between NMD and type II survivor formation was 
explored in this study. RAD51 is required for generation of type I survivors since it is involved in 
amplification of Y’ subtelomeric elements (Rubelj I., 2014-2015). Janke et al. (2016) have 
reported that mRNA levels of RAD51 are increased in mutants with non-functional NMD 
pathway. We hypothesized that RAD51 overexpression might promote type I survivor formation 
and that type II survivor generation would consequently be suppressed. In order to test that, 
several assays were performed with AKY5 and AKY6 strains. The single-colony streaking assay 
indicated that mutants with overexpressed RAD51 were able to form survivors. As described in 
section 3.6., the type of the survivors was established with telomere Southern blot. As expected, 
mutants without RAD51 overexpression (i.e. the ones grown on YPD) were able to form type II 
survivors, while mutants in which RAD51 was overexpressed (i.e. the ones grown on YPGal) 
formed type I survivors. Although only type I survivors were detected in all seven samples of the 
mutant grown on YPGal, it is possible that not enough time was provided for type II survivors to 
emerge and overtake the cultures. Furthermore, it is possible that the high concentration of Rad51 
blocked or delayed type II survivor formation. In future work, liquid senescence assay should be 
performed with AKY5 or AKY6 strain to clarify this issue.  
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5. Conclusion 
The study described here was done within the framework of a larger project carried out in Dr. 
Chang’s laboratory at ERIBA, which focused on the identification and characterization of genes 
important for type II survivor formation in S. cerevisiae. A genome-wide screen was performed 
at an early stage of the project and one of the identified hits was UPF2, a gene involved in NMD. 
My study focused on what was a logical next step – examining the dependence of type II survivor 
formation on NMD in more detail. Although only UPF2 was identified as a hit in the genome-
wide screen, the study seems to suggest that type II survivor formation is in some extent also 
dependent on UPF1 and UPF3. This could therefore imply that UPF2 does not have a specific 
function in type II survivor formation and that there is a connection between this process and 
NMD. This conclusion is also supported by the results reported by Hu et al. (2013). Surprisingly, 
results obtained in this study do not indicate that UPF2 is absolutely required for type II survivor 
formation. Nevertheless, as described in more detail in chapter 4, it is possible that UPF2 
partially blocks this process. Another finding of this study is that EBS1, a global inhibitor of 
translation, seems to be required for type II survivor formation, even if it is not one of the three 
genes involved in NMD. The study also pursued the idea that STN1 might be a potential link 
between NMD and type II survivor formation. The assays performed to examine this proposition 
have not confirmed it since their results are either inconclusive or indicating that STN1 is not a 
link. Nevertheless, it remains to be determined whether overexpression of STN1 can partially 
impair type II survivor formation. In the last stage of the study, stemming from the claim in 
literature that NMD regulates mRNA levels of genes involved in HR, we tested whether RAD51 
could represent the connection between NMD and inability of cells to form type II survivors. 
Although type II survivors were not detected in mutants with RAD51 overexpression, the 
assumption has to be further examined before a final conclusion can be reached. By way of a 
general conclusion we can say that, although the observations made in this study suggest that 
NMD is involved in the regulation of type II survivors, the exact link remains to be discovered.         
 
 
 
 
56 
 
6. Literature 
1. Addinall S. G., Holstein E. M., Lawless C., Yu M., Chapman K., Banks A. P., Ngo H. P., 
Maringele L., Taschuk M., Young A., Ciesiolka A., Lister A. L., Wipat A., Wilkinson D. 
J., Lydall D. 2011. Quantitative fitness analysis shows that NMD proteins and many other 
protein complexes suppress or enhance distinct telomere cap defects. PLoS Genet. 7(4). 
2. Advani V. M., Belew A. T., Dinman J. D. 2013. Yeast telomere maintenance is globally 
controlled by programmed ribosomal frameshifting and the nonsense-mediated mRNA 
decay pathway. Translation (Austin). 1(1). 
3. Brogna S., Wen J. 2009. Nonsense-mediated mRNA decay (NMD) mechanisms. Nat 
Struct Mol Biol. 16(2): 107-13. 
4. Chang M., Luke B., Kraft C., Li Z., Peter M., Lingner J., Rothstein R. 2009. Telomerase 
Is Essential to Alleviate Pif1-Induced Replication Stress at Telomeres.Genetics. 183(3): 
779–791. 
5. Conti E., Izaurralde E. 2005. Nonsense-mediated mRNA decay: molecular insights and 
mechanistic variations across species. Curr Opin Cell Biol. 17(3): 316-25. 
6. Cordin O., Banroques J., Tanner N. K., Linder P. 2006. The DEAD-box protein family of 
RNA helicases. Gene. 367: 17-37. 
7. Dahlseid J. N., Lew-Smith J., Lelivelt M. J., Enomoto S., Ford A., Desruisseaux M., 
McClellan M., Lue N., Culbertson M. R., Berman J. 2003. mRNAs encoding telomerase 
components and regulators are controlled by UPF genes in Saccharomyces cerevisiae. 
Eukaryot Cell. 2(1): 134-42. 
8. Enomoto S., Glowczewski L., Lew-Smith J., Berman J. G. 2004. Telomere cap 
components influence the rate of senescence in telomerase-deficient yeast cells. Mol Cell 
Biol. 24(2): 837-45. 
9. Ford A. S., Guan Q., Neeno-Eckwall E., Culbertson M. R. 2006. Ebs1p, a negative 
regulator of gene expression controlled by the Upf proteins in the yeast Saccharomyces 
cerevisiae. Eukaryot Cell. 5(2): 301-12. 
10. Gasparyan H. J., Xu L., Petreaca R. C., Rex A. E., Small V. Y., Bhogal N. S., Julius J. A., 
Warsi T. H., Bachant J., Aparicio O. M., Nugent C. I. 2009. Yeast telomere capping 
protein Stn1 overrides DNA replication control through the S phase checkpoint. Proc Natl 
Acad Sci U S A. 106(7): 2206-11.  
11. Grandin N., Charbonneau M. 2007. Control of the yeast telomeric senescence survival 
pathways of recombination by the Mec1 and Mec3 DNA damage sensors and RPA. 
Nucleic Acids Res. 35(3): 822-38. 
12. Grandin N., Damon C., Charbonneau M. 2000. Cdc13 cooperates with the yeast Ku 
proteins and Stn1 to regulate telomerase recruitment. Cell Biol. 20(22): 8397-408. 
13. Grandin N., Damon C., Charbonneau M. 2001. Ten1 functions in telomere end protection 
and length regulation in association with Stn1 and Cdc13. EMBO J. 20(5): 1173-83. 
57 
 
14. Grandin N., Reed S. I., Charbonneau M. 1997. Stn1, a new Saccharomyces cerevisiae 
protein, is implicated in telomere size regulation in association with Cdc13. Genes Dev. 
11(4): 512-27. 
15. Greenwood J., Cooper J. P. 2012. Non-coding telomeric and subtelomeric transcripts are 
differentially regulated by telomeric and heterochromatin assembly factors in fission 
yeast. Nucleic Acids Res. 40(7): 2956-63. 
16. Greider C. W. 2016. Regulating telomere length from the inside out: The replication fork 
model. Genes & Dev. 30: 1483-1491. 
17. Greider C. W., Blackburn E. H. 1985. Identification of a specific telomere terminal 
transferase activity in Tetrahymena extracts. Cell. 43(2 Pt 1): 405-13. 
18. Guan Q., Zheng W., Tang S., Liu X., Zinkel R. A., Tsui K. W., Yandell B. S., Culbertson 
M. R. 2006. Impact of nonsense-mediated mRNA decay on the global expression profile 
of budding yeast. PLoS Genet. 2(11). 
19. Holstein E. M., Clark K. R., Lydall D. 2014. Interplay between nonsense-mediated 
mRNA decay and DNA damage response pathways reveals that Stn1 and Ten1 are the 
key CST telomere-cap components. Cell Rep. 7(4): 1259-69. 
20. Hu Y., Tang H. B., Liu N. N., Tong X. J., Dang W., Duan Y. M., Fu X. H., Zhang Y., 
Peng J., Meng F. L., Zhou J. Q. 2013. Telomerase-null survivor screening identifies novel 
telomere recombination regulators. PLoS Genet. 9(1) 
21. Hug N., Longman D., Cáceres J. F. 2016. Mechanism and regulation of the nonsense-
mediated decay pathway. Nucleic Acids Res. 44(4): 1483-95. 
22. Hurt J. A., Robertson A. D., Burge C. B. 2013. Global analyses of UPF1 binding and 
function reveal expanded scope of nonsense-mediated mRNA decay. Genome Res. 
23(10): 1636-50. 
23. Isken O., Maquat L. E. 2007. Quality control of eukaryotic mRNA: safeguarding cells 
from abnormal mRNA function. Genes Dev. 21(15): 1833-56. 
24. Janke R., Kong J., Braberg H., Cantin G., Yates J. R., Krogan N. J., Heyer W. D. 2016. 
Nonsense-mediated decay regulates key components of homologous recombination. 
Nucleic Acids Res. 44(11): 5218-30.  
25. Janke C., Magiera M. M., Rathfelder N., Taxis C., Reber S., Maekawa H., Moreno-
Borchart A., Doenges G., Schwob E., Schiebel E., Knop M. 2004. A versatile toolbox for 
PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter 
substitution cassettes. Yeast. 21(11): 947-62. 
26. Lingner J., Hughes T. R., Shevchenko A., Mann M., Lundblad V., Cech T. R. 1997. 
Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 276(5312): 
561-7. 
27. Liu C. C., Gopalakrishnan V., Poon L. F., Yan T., Li S. 2014. Cdk1 regulates the 
temporal recruitment of telomerase and Cdc13-Stn1-Ten1 complex for telomere 
replication. Mol Cell Biol. 34(1): 57-70. 
58 
 
28. Lue N. F., Zhou R., Chico L., Mao N., Steinberg-Neifach O., Ha T. 2013. The telomere 
capping complex CST has an unusual stoichiometry, makes multipartite interaction with 
G-Tails, and unfolds higher-order G-tail structures. PLoS Genet. 9(1). 
29. Luke B., Azzalin C. M., Hug N., Deplazes A., Peter M., Lingner J. 2007. Saccharomyces 
cerevisiae Ebs1p is a putative ortholog of human Smg7 and promotes nonsense-mediated 
mRNA decay. Nucleic Acids Res. 35(22): 7688-97. 
30. McEachern M. J., Haber J. E. 2006. Break-induced replication and recombinational 
telomere elongation in yeast. Annu Rev Biochem. 75:111-35. 
31. McGlincy N. J., Smith C. W. 2008. Alternative splicing resulting in nonsense-mediated 
mRNA decay: what is the meaning of nonsense? Trends Biochem. Sci.  
33(8): 385-93. 
32. Mitchell P., Tollervey D. 2003. An NMD pathway in yeast involving accelerated 
deadenylation and exosome-mediated 3'-->5' degradation. Mol Cell. 11(5): 1405-13. 
33.  Muhlrad D., Parker R. 1994.  Premature translational termination triggers mRNA 
decapping. Nature. 370: 578–581. 
34. Nautiyal S., DeRisi J. L., Blackburn E. 2002. The genome-wide expression response to 
telomerase deletion in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 99(14): 
9316–9321. 
35. Ngo H. P., Lydall D. 2010. Survival and growth of yeast without telomere capping by 
Cdc13 in the absence of Sgs1, Exo1, and Rad9. PLoS Genet. 6(8). 
36. Petreaca R. C., Chiu H. C., Nugent C. I. 2007. The role of Stn1p in Saccharomyces 
cerevisiae telomere capping can be separated from its interaction with Cdc13p. Genetics 
177(3): 1459–1474. 
37. Rubelj, I. 2014.-2015. Biologija starenja. Kompilacija za studente.  
38. Sherman F. 2002. Getting started with yeast. Methods Enzymol. 350: 3-41. 
39. Singer M. S., Gottschling D. E. 1994. TLC1: template RNA component of 
Saccharomyces cerevisiae telomerase. Science. 266:404–409. 
40. Thomas B. J., Rothstein R. 1989. Elevated recombination rates in transcriptionally active 
DNA. Cell. 56(4): 619-30. 
41. Wang W., Cajigas I. J., Peltz S. W., Wilkinson M. F., González C. I. 2006. Role for 
Upf2p phosphorylation in Saccharomyces cerevisiae nonsense-mediated mRNA decay. 
Mol Cell Biol. 26(9): 3390-400. 
42. Webb C. J., Wu Y., Zakian V. A. 2013. DNA repair at telomeres: keeping the ends intact. 
Cold Spring Harb Perspect Biol. 5(6). 
43. Wellinger R. J., Wolf A. J., Zakian V. A. 1993. Saccharomyces telomeres acquire single-
strand TG1-3 tails late in S phase. Cell. 72(1): 51-60. 
44. Xiao W. 2006. Yeast protocols. Methods in molecular biology: 313. 2nd ed. Totowa, New 
Jersey: Humana Press. 
59 
 
Curriculum vitae 
 
PERSONAL INFORMATION 
Alan Kavšek                             
Grada G.Tadino 26, 10000 Zagreb, Croatia                    
1993alan@gmail.com    
 
EDUCATION  
since September 2014   Graduate student (MS level) of Molecular Biology                                    
All the courses of the two-year Master’s program completed, currently  
awaiting defense of the master’s thesis 
 
2011 – 2014     Undergraduate studies of Molecular biology, Faculty of Science,            
University of Zagreb (degree obtained: univ. bacc. biol. mol.)  
 
September 2007 – June 2011  Student at Classical Grammar School PKG, Zagreb  
 
 
EXTRA CURRICULAR PROFESSIONAL TRAINING  
March – October 2016 
• Working at the European Research Institute for the Biology of Ageing in Groningen in the group 
of assoc. prof. Michael Chang, completing the Master thesis project “Investigating the link 
between nonsense-mediated mRNA decay and survivor formation in S. cerevisiae”  
 
July – August 2015  
• Participating in The International Summer School (ISS) focusing on “Gene Regulation, 
Epigenetics and Genome Stability”. Working in Dr. Petra Beli’s lab at the Institute of Molecular 
Biology in Mainz on the project “Exploring the interaction between FEN1 and Cullin-RING 
ligases”  
  
July 2014  
• Working in prof. Klaus Förstemann’s laboratory for one month at the Gene Center  of the 
Ludwig-Maximilian University in Munich; learning about prof. Förstemann’s work  (Biogenesis 
and function of small RNAs) and doing practical work (form of a mini project)    
 
March – May 2014  
• Doing laboratory skill training and assisting in the lab of assoc. prof. Ivana Ivančić Baće at the 
University of Zagreb, Department of Molecular biology (the project involved studying CRISPR/Cas 
mechanism in E. Coli)   
  
 
60 
 
July 2013  
• 7-day visit to prof. Xavier Perret’s laboratory at the University of Geneva, Department of Botany 
and Plant biology; observing and learning about prof. Perret’s work (Genetics of symbioses 
between Sinorhizobium fredii NGR234 and legumes), spending time with his team and doing 
some basic practical work under their supervision  
  
July 2012  
• 5-day visit to prof. David Shore’s laboratory at the University of Geneva, Department of 
Molecular Biology; observing and learning about prof. Shore’s work (establishing relationship 
between chromosome structure and the process of gene regulation, DNA replication, 
chromosome segregation), spending time with his team and doing some basic practical work in 
lab under their supervision  
  
July 2010 
• Summer School of Science S3++, Višnjan, Croatia (team project in biology „Finding Antibiotic 
Resistance Genes Using Phyletic Profiling“)   
  
 
OTHER PROFESSIONAL ACTIVITIES 
 
2014 – 2015  
• Member of BIUS, Association of Biology students, Faculty of Science, University of Zagreb 
 
2012, 2013 
• Participated in the event Night of Biology, won the Special Award from the Rector of the 
University of Zagreb for the participation in the 2012 event 
 
July 2009 
• SEMEP (South-Eastern Mediterranean Environmental Project) regional meeting of secondary 
school students, island of Vis, Croatia (presentation on the threat posed in the Adriatic by 
Caulerpa Taxifolia)  
 
SKILLS  
Microsoft Office tools  
Sequence alignment algorithms 
PHYLIP - phylogeny software package  
Deep View (molecular graphics program)  
 
Driving license B  
HOBBIES  
Playing the guitar; sports (martial arts, parkour, skiing)  
  
LANGUAGES  
Croatian – mother tongue; English – C1.2 certificate; German  
61 
 
Životopis 
 
OSOBNE INFORMACIJE 
Alan Kavšek                             
Grada G.Tadino 26, 10000 Zagreb                     
1993alan@gmail.com  
  
OBRAZOVANJE  
od rujna 2014.   Diplomski studij molekularne biologije (apsolvent)  
Prirodoslovno- matematički fakultet Sveučilišta u Zagrebu 
 
2011. – 2014.     Preddiplomski studij molekularne biologije  
Prirodoslovno- matematički fakultet Sveučilišta u Zagrebu; 
završen studij (192 ECTS) i stečeno zvanje Sveučilišni prvostupnik 
(Baccalaureus) molekularne biologije u rujnu 2014.  
 
rujan 2007. – lipanj 2011.  Privatna klasična gimnazija, Zagreb; u lipnju 2011. položena državna 
matura iz šest predmeta (obavezni predmeti na višoj razini) 
 
 
STRUČNO OSPOSOBLJAVANJE  
ožujak - listopad 2016.  
• Rad na  Europskom istraživačkom institutu za biologiju starenja (ERIBA) u Groningenu, u 
laboratoriju  izv. prof. dr.sc. Michaela Changa kao stipendist programa Erasmus+; provedeno 
istraživanje za diplomski rad pod naslovom  “Investigating the link between nonsense-mediated 
mRNA decay and survivor formation in S. cerevisiae”  
 
srpanj – kolovoz 2015.  
• Međunarodna ljetna škola (ISS) na području regulacije gena, epigenetike i stabilnosti genoma: 
pohađanje predavanja te rad u laboratoriju dr. sc. Petre Beli na Institutu za Molekularnu 
biologiju u Mainzu na projektu “Exploring the interaction between FEN1 and Cullin-RING 
ligases”  
  
srpanj 2014.  
• Jednomjesečni boravak i rad u laboratoriju prof. dr.sc. Klausa Förstemanna u Centru za 
istraživanje gena (Gene Center) Sveučilišta Ludwig-Maximilian u Münchenu; upoznavanje s 
radom laboratorija i projektom prof. Förstemanna „Biogenesis and function of small RNAs“ te 
izvođenje praktičnog rada u obliku mini-projekta    
 
 
 
62 
 
ožujak – svibanj 2014.  
• Stručna praksa u laboratoriju izv. prof. dr. sc. Ivane Ivančić Baće na Prirodoslovno-
matematičkom fakultetu Sveučilišta u Zagrebu, u Zavodu za molekularnu biologiju, upoznavanje 
sa CRISPR/Cas sustavom na modelu E. Coli  
  
srpanj 2013.  
• 7-dnevni posjet laboratoriju prof. dr. sc.  Xaviera Perreta u Zavodu za botaniku i biologiju biljaka  
Sveučilišta u Ženevi; stjecanje osnovnih laboratorijskih vještina te učenje o projektu prof. Perreta   
(„Genetics of symbioses between Sinorhizobium fredii NGR234 and legumes“), praćenje rada 
drugih članova tima  
  
srpanj 2012.  
• 5-dnevni posjet laboratoriju prof. dr.sc. Davida Shorea u Zavodu za molekularnu biologiju 
Sveučilišta u Ženevi; praćenje i upoznavanje rada prof. Shorea („Establishing relationship 
between chromosome structure and the process of gene regulation, DNA replication, 
chromosome segregation“), praćenje rada drugih članova tima te stjecanje osnovnih 
laboratorijskih vještina uz njihovo mentorstvo  
  
srpanj 2010. 
• Ljetna škola znanosti S3++ u Znanstveno-edukacijskom centru u Višnjanu; rad na grupnom 
projektu „Finding Antibiotic Resistance Genes Using Phyletic Profiling“ 
 
 
OSTALE STRUČNE AKTIVNOSTI 
 
2014. – 2015.  
• Član BIUS-a, Udruge studenata biologije na Prirodoslovno-matematičkom fakultetu Sveučilišta u  
Zagrebu 
 
2012., 2013. 
• Sudjelovanje u manifestaciji „Noć biologije“, što je 2012. god. nagrađeno Posebnom nagradom  
Rektora Sveučilišta u Zagrebu   
 
srpanj 2009. 
• Sudjelovanje na regionalnom skupu učenika srednjih škola SEMEP (South-Eastern Mediterranean 
Environmental Project) na otoku Visu, prezentacija o Caulerpi Taxifolii i opasnosti koju 
predstavlja za Jadransko more  
 
VJEŠTINE  
Računalne vještine: alati Microsoft Office™ , programi za sravnjivanje sekvenci, PHYLIP (phylogeny 
 software package), program za molekularnu grafiku Deep View  
 
Vozačka dozvola B kategorije 
 
63 
 
HOBIJI  
Sviranje gitare  
Sport (borilačke vještine, parkour, skijanje)  
  
JEZICI  
hrvatski (materinski) 
engleski (svjedodžba za razinu C1.2) 
njemački   
 
 
 
 
 
APPENDIX I 
Growth media and plates used in the study 
YPD broth 
• per 500 mL: 
o 5 g yeast extract 
o 10 g peptone 
o to 480 mL with demi H2O 
o 20 mL of 50% glucose 
 
YPGal broth 
• per 500 mL: 
o 5 g yeast extract 
o 10 g peptone 
o to 450 mL with demi H2O 
o 50 mL of 20% galactose 
 
YPD plates 
• per liter: 
o 10 g yeast extract 
o 20 g peptone 
o 20 g agar 
o 1 pellet of NaOH 
o to 960 mL with demi H2O 
o 40 mL of 50% glucose 
 
YPGal plates 
• per liter: 
o 10 g yeast extract 
o 20 g peptone 
o 20 agar 
o 1 pellet of NaOH 
o to 900 mL with demi H2O 
o 100 mL of 20% galactose 
 
YPD+Cu plates 
• per liter: 
o 10 g yeast extract 
o 20 g peptone 
 
 
o 20 agar 
o 1 pellet of NaOH 
o to 999 mL with demi H2O 
o 1 ml of 100 mM CuSO4 
 
YPD+G418 plates 
• per liter: 
o 10 g yeast extract 
o 20 g peptone 
o 20 g agar 
o 1 pellet of NaOH 
o to 960 mL with demi H2O 
o 40 mL of 50% glucose 
o 1 mL of 200 mg/mL G418 
 
YPD+G418 plates contain antibiotic geneticin (G418), final concentration of which was 200 
mg/L. G418 blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic 
and eukaryotic cells. Only yeast cells that possess kanamycin-resistance marker (kanMX) can 
grow on media with geneticin. 
 
YPD+NAT plates 
• per liter: 
o 10 g yeast extract 
o 20 g peptone 
o 20 g agar 
o 1 pellet of NaOH 
o to 960 mL with demi H2O 
o 40 mL of 50% glucose 
o 500 µL of 200 mg/mL clonNAT 
 
YPD+NAT plates contain antibiotic nourseothricin (clonNAT) that blocks protein biosynthesis. 
Final concertation of this antibiotic was 100 mg/L. Yeast cells that can grow on these plates 
contain nourseothricin-resistance marker (natMX) that confers resistance to the antibiotic. 
Minimal (SD) media plates 
• per liter: 
o 1.3 g dropout mix* 
o 6.7 g yeast nitrogen base without amino acids 
o 20 g agar 
 
 
o 1 pellet of NaOH 
o to 960 mL with demi H2O 
o 40 mL of 50% glucose 
• *dropout mix: 
o for SD-his plates, –his dropout mix was used 
o for SD-ura plates, –ura dropout mix was used 
 
 
Nutrient Amount in dropout mix (g) 
Adenine (hemisulfate salt) 2.5 
L-arginine (HCl) 1.2 
L-aspartic acid 6.0 
L-glutamic acid (monosodium salt) 6.0 
L-histidine 1.2 
L-leucine 3.6 
L-lysine (mono-HCl) 1.8 
L-methionine 1.2 
L-phenylalanine 3.0 
L-serine 22.5 
L-threonine 12.0 
L-tryptophan 2.4 
L-tyrosine 1.8 
L-valine 9.0 
Uracil 1.2 
• –his dropout mix lacks histidine but contains the other nutrients listed in the table. 
• –ura dropout mix lacks uracil but contains the other nutrients listed in the table. 
 
SD-URA plates and SD-HIS plates are minimal media plates that are prepared without uracil or 
histidine. Yeast cells that grow on SD-URA plates contain URA3 marker and the ones that can 
grow on SD-HIS plates have HIS3 marker. URA3 is a gene  located on chromosome V. URA3 
encodes orotidine-5’phosphate decarboxylase, an enzyme required for the biosynthesis of uracil. 
HIS3 is a gene located on chromosome XV. This gene codes for imidazoleglycerol-phosphate 
dehydratase, an enzyme that catalyzes the sixth step in histidine biosynthesis. 
minSPO plates 
• per litre: 
o 10 g KOAc 
o 50 mg ZnOAc  
o 20 agar (washed 3x with demiH2O) 
o 1 pellet of NaOH 
o to 1 L with demi H2O 
o 2.5 mL of SPO supplement (kept at 4°C) 
 
 
 
 
APPENDIX II 
Solutions used for Li/Ac transformation  
10x TE  
• 100 mM Tris-Cl (pH=7.4) 
• 10 mM EDTA 
10x LiAc  
• 1 M LiAc 
 
 
1x TE/LiAc  
• 10x TE 
• 10x LiAc 
• dH2O 
40% PEG4000  
• 10x TE 
• 10x LiAc 
• 50% PEG4000 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX III 
Solutions used for Southern blot  
 
20x SSC (pH=7) 
• 3 M NaCl 
• 0.34 M C6H5Na3O7 
5x DIG wash buffer (pH=7.5) 
• 0.5 M Maleic acid 
• 0.75 M NaCl 
• 1.5% Tween 20 
Maleic acid buffer (pH=7.5) 
• 0.1 M Maleic acid 
• 0.15 M NaCl 
DIG detection buffer (pH=9.5) 
• 0.1 M Tris-HCl 
• 0.1 M NaCl 
Denaturing solution (pH>>10) 
• 1.5 M NaCl 
• 0.5 M NaOH 
 
Neutralization solution (pH=7.5) 
• 0.5 M Tris-HCl 
• 1 M NaCl 
10x Blocking solution 
• Blocking reagent (Roche) diluted in Maleic acid buffer 
 
 
